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Like a virus needs a body 
As soft tissue feeds on blood 
Someday I'll find you, the urge is here… 
…Like a virus, patient hunter 
I'm waiting for you, I'm starving for you… 
Björk – Virus, Biophilia 

ABSTRACT 
Stress granules (SG) are dynamic RNA/protein assemblies in the cytoplasm of the cell, formed 
under conditions of oxidative stress, heat shock or viral infections. These stress conditions trigger 
a sudden translational arrest, leading to a rapid switch of translation from housekeeping genes to 
stress-related factors. SGs fulfil multiple roles in the cell one of which is acting as triage centres 
for mRNA, where the mRNA is stored pending either degradation or reinitiation of translation. 
Many proteins are sequestered to SGs, among them signalling molecules, which make SGs signal 
centres to communicate a “state of emergency”. The importance of SGs is also underlined by the 
fact that they restrict viral propagation. The assembly of SGs is dependent on many RNA-binding 
proteins, one of which is G3BP (Ras-GAP SH3 domain binding protein). Semliki Forest virus 
(SFV) belongs to the alphaviruses, a large group of arthropod-borne animal viruses including 
several relevant human pathogens such as the re-emerging Chikungunya virus (CHIKV). 
Alphavirus infections lead to fever, rashes, arthralgia and can be lethal. Recent CHIKV outbreaks 
in the Caribbean area and the US, brings alphavirus research back on the agenda. Therefore there 
is a need to understand the molecular mechanisms how alphaviruses interact with their host. The 
aim of this thesis was to dissect virus-host cell interactions in the early response to alphavirus 
infection.  
Alphavirus infection leads to the formation of SGs at very early time points. Interestingly, they 
dissolve in the vicinity of viral replication complexes at later time points. In paper I, we showed 
that the non-structural protein nsP3 of SFV is responsible for sequestration of G3BP to replication 
complexes, by doing so, actively disassembling SGs and blocking their reformation. We mapped 
the binding site for G3BP to two C-terminal repeat domains of nsP3. A recombinant virus mutant 
lacking these repeats showed a longer and more persistent stress response and was attenuated in 
growth. 
In paper II, we extended this finding to the closely related CHIKV. Our results show that nsP3 of 
both SFV and CHIKV interact with G3BP via two C-terminal repeat domains and that the 
proline-rich region of nsP3 is dispensable for this interaction.  
In paper III we investigated the interaction between nsP3 and G3BP in molecular detail and 
determined that the residues FGDF in the C-terminal repeats of nsP3 are the G3BP binding motif. 
We further asked whether other proteins use the same mechanism as nsP3 to bind G3BP and 
whether this interaction inhibits the formation of SGs. We revealed that the phenylalanines and 
the glycine in the FGDF are essential for binding G3BP. We further demonstrated that the cellular 
ubiquitin-specific protease 10 (USP10) and the herpes simplex virus (HSV) protein ICP8 
(infected cell protein 8) also bind G3BP via an FGDF motif. In addition we show that the FGDF-
mediated binding to G3BP leads to a negative regulation of G3BP’s SG-nucleating function. 
Lastly we present a 3D-model of G3BP bound to an FGDF-containing peptide, which we 
validated by site-directed mutagenesis. 
Our findings present a common FGDF motif to bind G3BP, which has a negative regulatory 
effect on the SG-nucleating function of G3BP. This molecular mechanism and the presented 3D-
model demonstrate the therapeutic potential of targeting this interaction.
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1 INTRODUCTION 
1.1 VIRUSES 
1.1.1 Why we study viruses 
The word “information” is derived from the Latin verb informare, which originally means “to 
give form to the mind”, “to discipline”, “instruct” or “teach”. A virus is information in the 
form of DNA or RNA, surrounded by a protein coat and/or an envelope and delivered to a 
receiver which understands the syntax and is therefore taught, or instructed, to form new 
virus particles. We are surrounded by billions of viruses and encounter them every day. 
Viruses reside in our lungs, gastrointestinal, and urogenital tracts, and other places. The 
numbers are just astonishing, for example it is estimated that there are more than 1030 
bacteriophages in the world’s water supply. Arranged together head to tail they would extend 
to outer space more than 200 million light years. The nearest galaxy, Andromeda is only 2.5 
million light years away.  
With such constant exposure to viruses, it is amazing that they have relatively little impact on 
our health. This is, at least in part, due to our immune defence systems, which have evolved 
to fight viruses and other microbial infections. But when these defence systems are 
compromised even a common cold (caused by rhinoviruses) can be lethal. Nevertheless, there 
are still viruses which lead to devastating human diseases like AIDS, Ebola hemorrhagic 
fever, hantavirus pulmonary syndrome, rabies, smallpox, measles, influenza, poliomyelitis 
and others. Viruses are also thought to be responsible for approximately 15% of human 
cancers (zur Hausen, 1991). This underlines the biomedical importance of these agents. 
Viruses are passive agents which are totally dependent on the mercy of their environment. In 
an infected cell they act as obligate intracellular parasites. However, the dependency of 
viruses on their hosts for propagation makes them unique tools to study the biology of cells. 
Viral infection induces reprogramming of cellular mechanisms and this provides insights into 
the cellular biology as well as the function of host defence systems. Additionally, viruses can 
be manipulated with ease to generate useful virus mutants to further study cellular 
mechanisms. Therefore studies of virus-infected cells have contributed to our understanding 
of cell biology and for example the protein synthesis machinery. The 5´cap structure was first 
identified on the viral RNA of the vesicular stomatitis virus (VSV) (Rhodes et al., 1974, 
Muthukrishnan et al., 1975). New translation initiation mechanisms, such as internal 
ribosomal entry sites (IRES) were discovered in virus-infected cells (Jang et al., 1988, 
Pelletier and Sonenberg, 1988), which are now found in cellular mRNA as well. Moreover, 
the investigation of oncoviruses, which can cause cancer, revealed the genetic basis of the 
disease. Finally, alphaviruses like Semliki Forest virus (SFV) have been used extensively as 
model envelope viruses to study the biology of viral infection and the biology of cells. The 
alphaviruses now represent one of the best-defined animal virus systems. However, there are 
still interactions between virus and the host cell which are not discovered. 
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1.2 SEMLIKI FOREST VIRUS 
1.2.1 Background 
Semliki Forest virus (SFV) is a positive-sense, single-stranded RNA virus and belongs to 
group IV in the Baltimore classification system. This group represents the largest of all 
groups. The most important animal and human pathogens and also plant viruses belong to 
this group, like SARS-CoV, poliovirus, hepatitis C virus, Norwalk virus, potato virus Y and 
many more. In 1942, SFV was first isolated in the Semliki Forest of Uganda. The virus is 
spread by mosquitoes and infects small animals and humans. SFV itself is a mild human 
pathogen, causing fever, rashes and joint pain. But closely related family members like 
Chikungunya virus (CHIKV) cause severe illness in humans with symptoms like high fever, 
rashes, headache and severe and persistent joint pain, in rare cases it can be fatal. Generally, 
CHIKV is spread by the mosquito Aedes aegypti, which is distributed in South America, 
Central, West and East Africa, India and South East Asia (Schwartz and Albert, 2010). In 
2005‒2006 CHIKV entered South West Indian Ocean Islands and the situation changed 
suddenly, because CHIKV adapted rapidly to mosquitoes of the species Aedes albopictus 
through a single point mutation in one of the glycoprotein genes of the virus. This mutation 
(A226V) in the glycoprotein E1 is associated with an increased replication capacity in this 
worldwide disseminated and invasive vector (Tsetsarkin et al., 2007). A. albopictus is also 
found in Southern Europe, where it seems to be held back by the Alps to reach further north. 
However due to global warming and heavy traffic in Europe, it could be a matter of time until 
this mosquito can reach other parts of Europe. 
In December 2013 on the island of Saint-Martin, in the French West Indies the first evidence 
for cases of CHIKV infection in the Western hemisphere was reported. (Leparc-Goffart et al., 
2014). Four months later, at the end of March 2014, nine Caribbean islands reported cases of 
CHIKV infections, and at the end of April 2014, 15 Caribbean islands claimed cases 
(Morrison, 2014, Nasci, 2014) of CHIKV infections. The Centers for Disease Control and 
Prevention (CDC) in the US reported in July 2014 the first locally acquired case in Florida, 
indicating that CHIKV has reached the continental United States.  
SFV and CHIKV belong to the family Togaviridae, which consists of two virus genera, 
alphavirus and rubivirus. There is only one member of the rubivirus genus, rubella virus, 
which infects only humans and for which no insect vector is known. In contrast, more than 30 
members of the alphavirus genus are known, some of which are pathogenic for humans and 
animals (Strauss, 1994). Alphaviruses are distributed worldwide and grouped into New 
World and Old World alphaviruses. Old World alphaviruses include CHIKV, SFV, Sindbis 
virus (SINV) and Ross River virus (RRV). They are found in Europe, Asia, Africa and 
Australia. New World alphaviruses can be found in South and North America, for instance, 
Venezuelan equine encephalitis virus (VEEV), Eastern equine encephalitis virus (EEEV) and 
Western equine encephalitis virus (WEEV). Those viruses infect mainly horses and rodents 
and lead to encephalitis, which can cause death. Human beings can be infected by mosquito 
bites. 
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Replication of alphaviruses occurs in invertebrate vectors and vertebrate hosts. The viruses 
spread between individuals or species by blood-sucking mosquitoes, which makes 
alphaviruses a member of the group of arboviruses (arthropod borne). An alphaviral infection 
is asymptomatic and persists life-long in the mosquito. Interestingly, this can be also 
observed in in vitro systems with insect cells, where the acute infection is limited and 
converted to a persistent infection without killing the host cell (Strauss, 1994). This is not the 
case for vertebrate cells, where the infection leads to rapid cell death (Strauss, 1994). In 
vertebrates, an acute infection can occur with symptoms like high fever, rashes and arthritis; 
in the case of infection with New World alphaviruses, encephalitis can also occur often 
ending with death. But normally an infection is cleared by the immune system. The recovery 
from the infection varies by age. Younger people recover in 5‒15 days, while elderly people 
need a longer time, around 1‒2.5 months (Simon et al., 2007, Taubitz et al., 2007). There are 
no specific treatments available nor have any vaccines been developed, tough vaccines 
against CHIKV are undergoing clinical evaluation (Weaver et al., 2012, Morens and Fauci, 
2014). Currently, the best prevention is mosquito control, by using mosquito repellents and 
wearing appropriate clothing. 
The most-studied members of the alphavirus genus are SFV and SINV. Nowadays the re-
emerging CHIKV gets more and more attention in the alphavirus research field, and there is a 
drastic increase in published literature in the CHIKV field. Nevertheless, the knowledge that 
was gathered by studying SFV and SINV are fundamental for our understanding of alphaviral 
infections. SFV and SINV are not associated with severe human diseases and therefore 
considered as safe model system to study alphaviral infections. A wide range of cells from 
invertebrates and vertebrates can be used to study SFV and SINV replication. The 
development of SINV (Rice et al., 1987) and SFV (Liljestrom and Garoff, 1991) infectious 
cDNA, allowed easy reverse genetics. A great deal has been learnt about alphaviral infections 
regarding RNA replication, transcription and viral polyprotein processing as well as basic 
cellular processes (Strauss, 1994, Jose et al., 2009). However, SFV, SINV and CHIKV are 
different viruses, and what has been learnt from one virus is not necessarily true for the 
others. Therefore care has to be taken if results from studying one virus are translated to 
explain the effects of another virus. SFV is also well known and used in the biotechnology 
field. It is used as a viral vector for the expression of heterologous proteins which have a 
potential use for vaccination or cancer gene therapy (Yamanaka, 2004, Riezebos-Brilman et 
al., 2006, Atkins et al., 2008, Johansson et al., 2012). 
 
1.2.2 Virion and genome organization 
The SFV particle contains a positive-sense single-stranded RNA genome. It has a length of 
approx. 11.7 kb (Jose et al., 2009). The genome is packed into an icosahedral nucleocapsid 
(NC), which is composed of 240 capsid monomers. The N-terminal part of the capsid 
monomer interacts with the genomic RNA. The nucleocapsid, with a diameter of 30 nm, is 
enveloped, increasing the size of the virion to approximately 70 nm. The envelope is derived 
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from the host plasma membrane and consists of 240 copies of a heterodimer of the E1-E2 
glycoprotein. Three E1-E2 heterodimers form a spike complex, which leads to a total of 80 
spike complexes on the surface. A third glycoprotein E3 is associated to each heterodimer. 
The E2 glycoprotein anchors the spike to the envelope by interacting with the nucleocapsid 
that lies beneath. Another important role for E2 is binding to the host cell receptor, which has, 
however, still not been identified. 
The RNA genome, which sediments at 42S in a sucrose gradient, hast two open reading 
frames (ORF). The 5´two thirds of the genome encode a polyprotein that is processed into 
four non-structural proteins (nsP) to form the viral replicase. A notable difference between 
different alphaviruses is that some (for example SINV and CHIKV, but not SFV) contain a 
leaky opal stop codon (UGA) at the end of the sequence of nsP3. Expression of the non-
structural polyprotein thus leads primarily to nsP123, but in 10–20% of the cases the read 
through leads to the expression of nsP1234 (Firth et al., 2011). In SFV, the opal stop codon 
has been replaced by an arginine codon (CGA), which means that only polyprotein nsP1234 
is expressed. The polyprotein undergoes highly regulated processing steps, whereby it is 
subsequently cleaved into different products with different RNA synthesis capabilities (Fig 
1), providing a mechanism for viral RNA synthesis (Fig.1 ) (Kääriäinen et al., 1987, Merits et 
al., 2001, Vasiljeva et al., 2001). The 3´ third of the genome, which is under the control of a 
subgenomic promoter that leads to a 26S subgenomic (sg)-RNA, encodes the structural 
proteins capsid, E3, E2, 6K, TF and E1. The 5´ end of the capsid protein-coding sequence 
contains a translational enhancer, which is needed for efficient translation of the structural 
proteins in an infected cell (Frolov and Schlesinger, 1994, Sjöberg et al., 1994). Another 
interesting feature of the 26S sg-RNA is that it contains a −1 frame shift signal in the 6K 
sequence, which leads to the expression of the transframe (TF) protein (Firth et al., 2008). 
 
1.2.3 Replication cycle 
SFV enters the cell by receptor-mediated clathrin-dependent endocytosis (Doxsey et al., 
1987). The glycoprotein E2 is the receptor-binding ligand. The virus is able to infect a large 
number of different cell types and also cells from various species. However the receptor is 
still unknown for most of the alphaviruses. For SINV, the laminin receptor has been proposed 
to be the binding receptor (Wang et al., 1992), and the binding is dependent on heparin 
sulphate (Klimstra et al., 1998). To date no specific receptor for SFV has been described. 
Once the virion is bound to the receptor on the cell surface, it is internalized by clathrin-
mediated endocytosis (Helenius et al., 1980, DeTulleo and Kirchhausen, 1998). Acidification 
of the endosomal lumen leads to a rearrangement of the (E1-E2)3 spike complex, which 
destabilizes the complex and exposes the fusion peptide of E1. This highly hydrophobic 
peptide gets inserted into the endosomal membrane for membrane fusion to occur (Kielian, 
2010). This event releases the nucleocapsid into the cytoplasm (Helenius et al., 1985, 
Wahlberg et al., 1992, Bron et al., 1993, Justman et al., 1993). Once the nucleocapsid is in the 
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cytoplasm, it is destabilised, and ribosomes bind to the capsid proteins (Singh and Helenius, 
1992). This event releases the viral RNA from the capsid, and the closely located ribosomes 
immediately start to express the non-structural polyprotein. 
 
 
The non-structural polyprotein is processed stepwise into four separate proteins. These 
proteins induce the formation of spherules at the plasma membrane, which are small 
protrusions sticking out from the plasma membrane. The spherules are then internalized 
through endocytosis and transported along microtubules to the perinuclear region (Spuul et 
al., 2010). During transport, they fuse with endosomes and lysosomes, which leads to the 
formation of CPV-I (type I cytopathic vacuoles). One spherule contains one dsRNA molecule 
and an unknown number of nsP molecules as well as host proteins (Spuul et al., 2010, 
Frolova et al., 2010). The processing of the non-structural polyprotein is very well controlled 
and executed by nsP2, which possesses a protease activity (Vasiljeva, 2003, Lulla et al., 
2006). Due to the temporal processing of the polyprotein, the different resulting replication 
complexes have different RNA synthesis specificities. At an early stage (4–6 h after SFV 
infection) nsP2 cleaves between nsP3 and 4, leading to the nsP123-nsP4 RC, which is mostly 
responsible for producing negative-sense ssRNA, the template for genomic viral RNA. Then, 
nsP1 is cleaved from the nsP123 polyprotein to result in nsP1 + nsP23, upon which both 
Figure 1: SFV genome organization. The positive single-stranded 42S genome is capped (5´ m7GpppA) and
polyadenylated. The incoming 42S genome is translated into the non-structural polyprotein nsP1234. The minus strand
replicase nsP123 + nsP4 replicates the 42S genome into a minus strand replicative intermediate. The fully processed plus 
strand replicase replicates more positive strand 42S RNA and transcribes a 26S subgenomic (sg)-RNA via the 26S RNA
promoter. The 26S sg-RNA is then translated into the structural proteins. The RNAs are shown as open boxes whereas the 
translated ORFs and individual proteins are shown in grey. Adapted from (Strauss, 1994). 
 6 
negative- and positive-strand RNA molecules are synthesised. After further processing of the 
nsP23 molecule, the replication of full-length 42S genomic RNA and of the 26S (sg)-RNA 
can occur from the minus strand RNA template. At this point the fully processed non-
structural protein complex (nsP1 + 2 + 3 +4) is not able to make minus strand RNA, but the 
synthesis of positive strand continues until the cell dies (Fig 1). The produced 42S genomic 
RNA interacts with newly synthesised capsid proteins, and nucleocapsids are formed in the 
cell (Lemm et al., 1994, Shirako and Strauss, 1994, Vasiljeva, 2003). 
 Non-structural proteins 1.2.3.1
nsP1 is a membrane-binding protein composed of 537 amino acids (aa) and is involved in the 
synthesis of the m7GpppA cap0 structure for the 42S RNA and the 26S sg-RNA. nsP1 is 
tightly bound to membranes in the context of the polyprotein as well as in the mature 
replicase complex (Salonen et al., 2003). It is essential that the replicase complex is bound to 
membranes. Studies have revealed that point mutations in the membrane-inserted alpha helix 
(245–264) are lethal to SFV (Ahola et al., 1999, Spuul et al., 2007). There are also three serial 
cysteines in the SFV nsP1 protein, spanning amino acids 418–420, which are post-
translationally palmitoylated. This modification strengthens the membrane binding but is not 
required for enzymatic activity. Palmitoylation of nsP1 induces the formation of filopodia-
like structures. However the mechanism and function of these structures is still unknown, but 
they could play a role in transmission of SFV from cell to cell (Laakkonen et al., 1996, 
Laakkonen et al., 1998). nsP1 catalyses the capping of the 42S genomic RNA and 26S sg-
RNA. The first reaction is, however, performed by nsP2, which has an RNA triphosphatase 
activity to remove the phosphate at the 5´ end of the RNA. The next two steps are performed 
by nsP1 (Mi and Stollar, 1991, Laakkonen et al., 1994). The guanyltransferase domain of 
nsP1 forms a complex with guanosine monophosphate (GMP). In the next step, nsP1 
transfers a methyl group from S-adenosylmethionine to the nsP1-GMP complex, this is 
catalysed by the methyltransferase activity of nsP1 and nsP1-m7GMP is generated. (Ahola 
and Kääriäinen, 1995). Interestingly, this reaction differs from the reactions in cells to 
produce the cap0 structure, whereby the GMP is first covalently bound to RNA and 
subsequently methylated. It is still not known which enzyme performs the last step to 
covalently bind the alphaviral cap to the RNA. 
The non-structural protein 2 is the largest protein of the replication complex, with a size of 
799 aa. It has multiple known enzymatic activities and roles. The N-terminus contains 
helicase (Gomez de Cedrón et al., 1999), RNA triphosphatase and nucleoside triphosphatase 
activities (Rikkonen et al., 1994a, Vasiljeva et al., 2000). A papain-like cysteine protease 
domain can be found at the C-terminus of nsP2, as well as an enzymatically non-functional 
methyltransferase-like domain (Strauss et al., 1992, Vasiljeva et al., 2001). The development 
of cytopathic effects is caused by the methyltransferase-like domain, which differentially 
modulates host defence mechanisms (Mayuri et al., 2008). The protease activity is 
responsible for the processing of the non-structural polyprotein (Strauss et al., 1992). The 3-
dimensional structure of the C-terminus spanning residues 468–787 of VEEV-nsP2 has been 
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solved by X-ray crystallography, revealing that the folding of the protease domain of nsP2 is 
novel compared to other proteases (Russo et al., 2006). nsP2 whether free or as part of the 
non-structural polyprotein is catalytically active. The cleavage of the polyprotein is very well 
orchestrated and depends on the stoichiometry of available products. Another interesting 
feature of nsP2 is that approximately 50% of the free nsP2 protein is found in the nucleus 
(Peränen et al., 1990) and that it contains multiple nuclear localization sequences (NLS) at the 
N-terminal and C-terminal regions (Rikkonen et al., 1994b). Mutational studies on the NLS 
and the abolishment of nsP2 translocation to the nucleus yielded an attenuated phenotype 
(Kääriäinen and Ahola, 2002, Fazakerley et al., 2002, Tamm et al., 2008), later shown to be 
due to a defect in the virus capacity to inhibit the type I interferon response (Breakwell et al., 
2007). 
nsP3, with a size of 482 aa, has been enigmatic for a long time, but recent discoveries have 
shed a light on the functions of nsP3. The protein can be divided into three major regions 
(schematically depicted in Fig. 2). The N-terminal region with 160 aa contains a so-called 
macro domain, which is conserved among alphaviruses as well as rubiviruses, herpesviruses 
and coronaviruses (Koonin and Dolja, 1993). The macro domain can bind ADP-ribose, 
poly(ADP-ribose) and RNA. The latter might be the main function of the nsP3 macro domain 
(Malet et al., 2009, Neuvonen and Ahola, 2009). It has also been shown that the N-terminal 
domain of nsP3 has a role in non-structural polyprotein processing (Lulla et al., 2012). The 
central domain or alpha domain, which also spans around 160 aa, is conserved among 
alphaviruses (Strauss, 1994). This region was crystallized as part of the nsP2-nsP3 
polyprotein. It has been demonstrated that this region binds zinc ions, and mutational studies 
revealed that this interaction is essential for the virus (Shin et al., 2012). The 3D-structure 
suggests that this region participates in RNA binding as well. The C-terminal part of nsP3 
consists of hypervariable sequences, the length of which is different in the various 
alphaviruses. The domain is basically unstructured, but it contains areas of functional 
similarities between the different alphaviruses. Two conserved sequence elements 
L/ITFGDFD (numbering of the motif: L/I1T2F3G4D5F6D7) close to the C-terminus and a 
degradation signal in the last 10 aa have been described (Varjak et al., 2010). Some of the 
motifs are shared among the alphaviruses and some are not. Several reports have shown that 
nsP3 is involved in interacting with cellular proteins such as Ras-GAP SH3 domain binding 
protein (G3BP), a SG-nucleating protein (see below) (Cristea et al., 2006, Frolova et al., 
2006, Gorchakov et al., 2008, Fros et al., 2012). Nevertheless G3BP was also reported to 
interact with nsP2 (Atasheva et al., 2007) and nsP4 in SINV-infected cells (Cristea et al., 
2010). Recently a proline-rich element in the hypervariable domain (HVD) was shown to 
interact with amphiphysin-1 and -2. This interaction was shown to promote viral replication 
but the mechanism was not described (Neuvonen et al., 2011). A cluster of phosphorylated 
threonines and serines can be found between the second (alpha) and third (hypervariable) 
domain. 16 phosphorylation sites are found in SFV, located within 50 aa, six of which (S320, 
327, 332, 335 and T344, 345) account for the majority of the phosphorylation of nsP3. Mutation of 
the phosphorylation sites has a relatively slight effect on replication in mammalian cells 
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infected with SFV or VEEV (Vihinen, 2000, Foy et al., 2013). On the other hand, it was 
shown that the phosphorylation plays a role in negative-strand synthesis in SINV-infected 
cells (de Groot et al., 1990, Dé et al., 2003). If nsP3 is expressed alone, it localizes to 
cytoplasmic non-membranous granules of different sizes. However, when expressed in the 
context of the nsP123 polyprotein, nsP3 is first localized at the plasma membrane and then 
triggers the re-localization to endosomal membranes, which appear similar to CPVs (Salonen 
et al., 2003, Salonen et al., 2005, Spuul et al., 2010). nsP3 does not have any catalytic 
activity; it is thus likely that it plays a role as a scaffolding protein. The C-terminus of nsP3 is 
intrinsically unstructured, which could play a role in interacting with several cellular partners 
(Cristea et al., 2006, Gorchakov et al., 2008, Neuvonen et al., 2011, Varjak et al., 2013).  
 
The RNA-dependent RNA-polymerase (RdRp) activity resides in the nsP4. The C-terminus 
shows sequence homology with other known RdRps, including the highly conserved GDD 
motif. The N-terminus (approx. 100 aa) does not display any similarities with other known 
sequences from viruses or cells, but they are conserved between the alphaviruses. Genetic 
evidence suggests that these sequences are involved in interactions with other non-structural 
proteins, but the function is still unknown (Rupp et al., 2011). The levels of nsP4 in infected 
cells are relatively low, for two reasons: First, an opal stop codon is located at the end of the 
nsP3-encoding sequence of most alphaviruses (but not SFV), which leads to lower levels of 
the polyprotein nsP1234 (Strauss, 1994). Secondly, the first amino acid of nsP4 is always a 
tyrosine residue, which is a very unusual feature. The tyrosine at the N-terminus of a protein 
is a destabilizing amino acid (Varshavsky, 1996), leading to rapid degradation of the protein 
by the proteasome. Interestingly, nsP4 is protected from degradation when it is incorporated 
into the replication complex (de Groot et al., 1991). Furthermore the polymerase activity 
requires a Tyr at the N-terminus, the only acceptable residues being other aromatic residues 
or histidine. Methionine is tolerated, whereas other residues are lethal for virus replication, 
resulting in reversions and selection for mutations in nsP4 (Shirako and Strauss, 1998).  
 Structural proteins 1.2.3.2
The formation of the replication complex composed of the individual non-structural proteins 
initiates the synthesis of the 26S sg-RNA, leading to the expression of the structural 
polyprotein, comprising the capsid, p62 (E3-E2), 6K, TF and E1 proteins. The capsid protein 
is autocatalytically cleaved from the structural polyprotein (Choi et al., 1991). This process 
Figure 2: Schematic representation of the non-structural protein 3 (nsP3). HVD: hypervariable domain, S: serine, T: 
threonine. For details see text. 
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exposes a signal peptide in E3, which results in the binding to and translocation of the nascent 
polypeptide across the endoplasmic reticulum (ER) membrane (Garoff et al., 1990). Several 
membrane-spanning regions can be found in the p62-6K-E1 polyprotein. In the ER, the p62-
6K-E1 is processed (glycosylated, palmitoylated) and cleaved into the proteins p62, 6K and 
E1 by cellular proteases (Melancon and Garoff, 1987). During the transport from the ER to 
the Golgi apparatus, p62 is further processed into E3 and E2 (Liljeström and Garoff, 1991, 
Strauss, 1994). E2 and E1 form heterodimers, which are assembled to a trimeric (E1-E2)3 
spike complex in the rough ER. The spikes are then further transported to the plasma 
membrane, where the formation of virions occurs (Ziemiecki et al., 1980, Mulvey and 
Brown, 1996, Lu et al., 1999). The viral RNA, which is bound to multiple copies of the 
capsid protein, accumulates at the plasma membrane and interacts with the cytoplasmic 
regions of E2 (Kail et al., 1991, Suomalainen et al., 1992, Skoging et al., 1996). The E3 
glycoprotein is also incorporated into the virus particles, but not in all alphaviruses (not 
SINV) (Sjöberg et al., 2011). The small 6K protein has been found to be incorporated into 
virions and is important for the correct assembly of the fully infectious SFV particle 
(Gaedigk-Nitschko and Schlesinger, 1990, Lusa et al., 1991, McInerney et al., 2004). The 
transframe (TF) protein, which is expressed upon a frameshift during translation, was 
reported to be incorporated into the virion as well, but the functions are unclear (Snyder et al., 
2013). 
 
1.2.4 Host response 
Viral infections are detected by the infected cells. Cells have developed certain 
countermeasures to restrict viral propagation. However, viruses have antagonized these 
countermeasures, leading to an arms race. SFV infection triggers a strong host response. SFV 
infection is primarily recognized via melanoma differentiation-associated protein 5 (MDA5) 
which leads to interferon-D/E production, but for efficient interferon-D/E production PKR is 
also required. Possibly by maintaining the integrity of the synthesized IFN-α/β mRNA, 
thereby allowing its translation (Barry et al., 2009, Schulz et al., 2010). PKR is a ubiquitously 
expressed enzyme, whereas its expression can be greatly enhanced by type I interferons. The 
enzyme recognizes double-stranded (ds) RNA, which is a replication intermediate formed 
during the replication of the minus and plus strand synthesis (Clemens and Elia, 1997, 
Clemens, 1997, Pindel and Sadler, 2011). Activated PKR phosphorylates the eukaryotic 
translation initiation factor 2 alpha (eIF2D) at serine 51. This is a very important regulation 
step for the initiation of eukaryotic protein translation. eIF2D is part of the ternary complex 
composed of eIF2, GTP and initiator Met-tRNA. This activated ternary complex meets the 
small 40S ribosomal subunit and other eukaryotic translation initiation factors to form the 
43S translation preinitiation complex at the cap structure of the mRNA. This complex scans 
the 5´ untranslated region for the AUG start codon, where the large 60S subunit joins the 
complex and translation of the protein begins. Once eIF2Dis phosphorylated, the guanine 
nucleotide exchange factor eIF2B gets sequestered to eIF2D and is then inhibited in its 
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function to exchange GDP for GTP in the ternary complex. Since the cellular concentration 
of eIF2B is much lower than that of eIF2D, even a small amount of phosphorylated eIF2D 
can suppress the eIF2B activity completely. The consequences are that the translation comes 
to a halt (Siekierka et al., 1982, Siekierka et al., 1984, Krishnamoorthy et al., 2001). Other 
important kinases which phosphorylate eIF2D, besides PKR, are the PKR-like endoplasmic 
reticulum kinase (PERK), Heme-regulated eukaryotic initiation factor eIF2D kinase (HRI) 
and general control nonderepressible 2 (GCN2). Misfolded proteins induce ER-stress that is 
sensed by PERK, a type I membrane protein in the ER, leading to the phosphorylation of 
eIF2D (Sood et al., 2000). Oxidative stress, for example treatment with sodium arsenite (Lu et 
al., 2001) leads to the activation of the HRI, which subsequently phosphorylates eIF2D. HRI 
is also activated by other stress signals like heat shock (Xu et al., 1997), heme depletion 
(Matts and Hurst, 1992, Chen et al., 1994, Chen and London, 1995) and osmotic shock (Lu et 
al., 2001). The kinase GCN2 senses amino acid deficiency through binding to uncharged 
tRNAs in the cytoplasm (Wek et al., 1995).  
PKR senses dsRNA via its C-terminal dsRNA-binding domain (dsRBD). Under normal 
conditions, an autoinhibitory domain blocks the kinase activity. The presence of dsRNA in 
the cytoplasm leads to dimerization of PKR by binding of two PKR molecules to one stretch 
of dsRNA. A subsequent autophosphorylation stabilizes the dimer, and conformational 
changes lead to the binding and subsequent phosphorylation of eIF2D (García et al., 2006). 
PKR is constitutively expressed in most cells but the expression can be greatly enhanced by 
the presence of IFN to counteract viral infections. Consequently, viruses have evolved 
strategies to circumvent the actions of PKR. For instance, the ICP34.5 protein of herpes 
simplex virus 1 (HSV-1) inhibits downstream effects of PKR by dephosphorylating eIF2D 
and thereby reverting PKR-induced translational shutoff (Mohr and Gluzman, 1996, He et al., 
1997). The NS1 protein of influenza A virus (IAV) (Lu et al., 1995) as well as the omega3 
protein from reovirus (Jacobs and Langland, 1998) bind and sequester dsRNA to prevent 
recognition by PKR. The E3L protein of vaccinia virus (VV) binds tightly to the catalytic 
cleft of PKR and blocks autophosphorylation (Sharp et al., 1998). Other viruses employ 
mechanisms independent of eIF2D. Cricket paralysis virus has distinct pseudoknot-like 
structures on the RNA that form multiple contacts with the ribosome independently of 
initiation factors (Jan and Sarnow, 2002). The 5´ end of the structural proteins of SFV and 
SINV contain a genetic element called translational enhancer element (Frolov and 
Schlesinger, 1994, Sjöberg et al., 1994). RNA sequence analysis predicts a very stable 
hairpin loop. The translational enhancement only occurs in infected cells (Sjöberg and 
Garoff, 1996). It was later shown that the translational enhancer element counteracts the 
inhibition of translation induced by the phosphorylation of eIF2D (McInerney et al., 2005, 
Ventoso et al., 2006). 
The type I interferons, which induce an innate antiviral state in the cell (Stark et al., 1998), 
were discovered in the supernatant of cells incubated with heat-inactivated virus. The 
supernatant interfered with the growth of live virus when added to the cells (Isaacs and 
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Lindemann, 1957). The type I interferons comprise several subtypes (IFN-DEHNZ(Liu, 
2005) IFN-α/β is primarily induced upon recognition of viral nucleic acids by host pattern 
recognition receptors (PRRs), such as proteins of the RIG-I-like receptor family, like 
MDA-5, retinoic acid inducible gene I (RIG-I), or a combination of the two (Takeuchi and 
Akira, 2009). RIG-I senses viral single-stranded RNA bearing a 5´ triphosphate (Yoo et al., 
2014). MDA5 senses long dsRNA intermediates which occur in the replication of positive-
sense ssRNA and dsRNA viruses during the minus-strand RNA synthesis (Feng et al., 
2012). SFV, for instance, is primarily recognized by MDA5 (Pichlmair et al., 2009) but also 
RIG-I (Schulz et al., 2010). IAV, Newcastle disease virus and VSV are sensed by RIG-I 
(Kato et al., 2006) and viruses such as murine norovirus-1, encephalomyocarditis virus 
(EMCV) Theiler’s murine encephalomyelitis virus (TMCV) by MDA5 (Gitlin et al., 2006, 
McCartney et al., 2008). The receptors signal through IFN-E promoter stimulator 1 (IPS-1), 
leading to the translocation of interferon regulatory factor 3 (IRF-3) and nuclear factor 
kappa B (NFNB) to the nucleus leading to the expression of type I interferons. Once 
induced and secreted, the type I interferons carry out the innate antiviral immune defence of 
cells by signalling via IFN-DE receptors in an autocrine and paracrine fashion. This leads 
to a signalling cascade involving the phosphorylation of the transcription factors STAT1 
and 2 and translocation to the nucleus, which induces the transcription of thousands of 
genes, called interferon-stimulated genes (ISGs). This signalling cascade induces an 
antiviral state in the cell. However, viruses counteract this response. The phosphatase VH1 
of VV interacts and dephosphorylates STAT1 and blocks the interferon gamma signalling 
transduction (Najarro et al., 2001, Koksal and Cingolani, 2011). Morbillivirus non-
structural protein 5 (NS5) blocks the type I interferon signalling pathway by interacting 
with the host non-receptor tyrosine-protein kinase 2 (TYK2) and thereby inhibiting 
downstream STAT1 and STAT2 phosphorylation (Chinnakannan et al., 2013). 
How does SFV deal with the cellular host response? The synthesis of cellular RNA and 
proteins is inhibited in vertebrate cells during alphavirus infection, but the synthesis of viral 
RNA and proteins is maintained. Gorchakov and coworkers showed that the transcriptional 
and translational shutdowns of the cellular macromolecule synthesis are independent events 
(Gorchakov et al., 2005). This leads to the limitation of the production of antiviral proteins, 
including type I interferons, which delays the induction of an antiviral state (Frolova et al., 
2002). The shutdowns appear to be driven at least in parts by nsP2 in the Old World 
alphaviruses and by the capsid protein in the New World alphaviruses (Gorchakov et al., 
2005, Garmashova et al., 2006, Aguilar et al., 2007, Breakwell et al., 2007). The presence 
of nsP2 causes the degradation of the DNA-directed RNA polymerase II subunit (RPB1) 
within the RNA polymerase complex II. RPB1 is ubiquitinated and then rapidly degraded 
by the proteasomal degradation pathway, which results in a decrease of host mRNA 
transcription (Akhrymuk et al., 2012). A different mode of action to downregulate cellular 
transcription is achieved by the New World alphaviruses. The capsid protein binds to 
importin DE and the nuclear export receptor RCM1. This complex then accumulates at the 
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nuclear pore and eventually inhibits the export of cellular mRNAs into the cytoplasm 
(Garmashova et al., 2007). 
The shutoff of the host translation machinery is influenced by a couple of mechanisms. The 
association of nsP2 with the ribosomal protein S6 (RpS6) suggests that alphaviruses modify 
the ribosome, which may contribute to differential translation of mRNA (Montgomery et 
al., 2006). Host translational shutoff is also mediated by the phosphorylation of eIF2D, via 
sensing of dsRNA by PKR. Interestingly phosphorylated eIF2D leads to the formation of 
SGs, which are cytoplasmic sites of aborted translation initiation complexes (Kedersha and 
Anderson, 2002), as described in detail below (chapter 1.3). SFV infection induces the 
formation of SGs, but as the infection progresses, the SGs are disassembled in the vicinity 
of replication complexes. The translation of the 26S sg-RNA is not affected by the 
phosphorylation of eIF2D. This is due to the translational enhancer residing at the 5´ end of 
the 26S sg-RNA, rendering the expression of the structural proteins unaffected of highly 
phosphorylated eIF2D(McInerney et al., 2005). 
 
1.3 STRESS GRANULES 
1.3.1 Background 
Stress granules (SGs) are cytoplasmic, non-membranous, phase dense structures which 
assemble in response to environmental stress. They are aggregates of aborted, translationally 
silenced messenger ribonucleoprotein particles (mRNPs), which are thought to be sites of 
mRNA storage and triage (Kedersha et al., 2002). They are formed in the cytoplasm upon 
various stress stimuli, like oxidative stress, heat shock or viral infections. The sequestration of 
mRNAs into SGs contributes to the rapid change of translation from housekeeping genes to 
heat shock proteins and other stress-related proteins (Anderson and Kedersha, 2009). Recent 
reports suggest that SGs could act as signal hubs, similar to transmembrane complexes such 
as the immunological synapse (Dustin, 2012), by recruiting important signalling proteins 
(Kedersha et al., 2013). Stress induces translational arrest, which causes the assembly of SGs 
in the cytoplasm, mediated by the phosphorylation of eIF2D (Kedersha et al., 1999). SGs are 
very dynamic structures, and their formation is orchestrated by numerous mRNA-binding 
proteins. The proteins shuttle in and out within seconds, whereas the SGs themselves last for 
minutes or even hours (Kedersha et al., 2005). The rapidly moving mRNPs create a large 
stable SG, in which the mRNPs are in a constant flux (like water in a river), whereas the SG 
as such (“the river”) is stable. SGs are assembled on untranslated mRNA by different mRNA-
binding proteins, which specify the fate of the mRNA in the given environmental conditions. 
The fate can be storage, degradation or reinitiation of translation. Furthermore SGs are in 
equilibrium with polysomes indicated by treatments with certain drugs: drugs which arrest 
translation elongation and stabilize polysomes, for example cycloheximide or emetine, lead to 
disassembly of SGs. Drugs that destabilize polysomes like puromycin promote the assembly 
of SGs (Kedersha et al., 2000). A very well described pathway of SG formation initiates with 
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the phosphorylation of eIF2D, which is executed by the kinases PKR, PERK, GCN2 and HRI 
(Kedersha et al., 1999, Kedersha et al., 2000, McEwen et al., 2005). Sodium arsenite, an 
oxidative stressor, activates HRI, GCN2 is activated during heat shock and nutrient 
starvation, PKR senses dsRNA during viral infection and PERK is activated by ER stress. 
However SG formation can also be induced by alternative pathways, independently of eIF2D 
phosphorylation, for instance, inhibition of the RNA helicase eIF4A through hippuristanol or 
pateamine A (Pat A) (Dang et al., 2006) or treatment of cells with 2-deoxyglucose, an 
inhibitor of glycolysis, leading to ATP depletion and an eIF2D-independent formation of SGs 
(Kedersha, 2001). 
Eukaryotic cells also contain other types of cytoplasmic RNA/protein granules, like 
processing bodies (PBs), exosome bodies, and neuronal bodies. PBs and exosome bodies are 
constitutively present and contain proteins of the mRNA decay machinery (Lin et al., 2007). 
Neuronal bodies are also constitutively present in the neuronal cells; they are foci that 
concentrate and transport silenced mRNPs along axons to the dendrites of neuronal cells 
(Knowles et al., 1996, Krichevsky and Kosik, 2001). 
 
1.3.2 SG assembly/disassembly 
The signalling cascade which leads to SGs assembly is very well described, but the 
mechanism how SGs actually assemble in the cytoplasm is less well understood. An essential 
component for the assembly of SGs is non-translating mRNA, as shown in cells treated with 
cycloheximide, which stalls polysomes on mRNA (Kedersha et al., 2000). An increasing pool 
of non-translated mRNA leads to the formation of SGs, a condition which can be induced by 
puromycin (Kedersha et al., 2000). Recent data on how SGs assemble suggest that low-
affinity interactions between intrinsically disordered (ID) regions of SG-nucleating and RNA-
binding proteins promote the formation of SGs (Kedersha et al., 2013, Malinovska et al., 
2013). One protein that promotes the reversible aggregation of untranslated mRNPs is the T-
intracellular antigen 1 (TIA-1). It contains a prion-related domain (PRD), which is a 
glutamine/asparagine (Q/N)-rich motif of low amino acid complexity that mediates the 
aggregation of the protein (Gilks et al., 2004). Prion-related sequences and low complexity 
(LC) regions are subtypes of ID proteins. ID regions can form multiple conformations, 
mediating transient interactions. These interactions can be influenced by the local 
environment, post-translational modifications and/or binding to other proteins (Uversky et al., 
2013, Malinovska et al., 2013). The SG-nucleating protein G3BP contains a serine residue at 
position 149 in its intrinsically disordered/low complexity (ID/LC) region. Phosphorylation 
of this residue alters the association with SGs by inhibiting the dimerization of G3BP 
(Tourrière et al., 2003). Similarly, tristetraprolin (TTP) can be phosphorylated at serine 
residues 52 and 178, also located in an ID/LC region. Phosphorylation leads to the exit of 
TTP from SGs, without altering its targeting to PBs (Stoecklin et al., 2004). Furthermore, the 
self-interacting domain of G3BP also promotes the formation of SGs. Deletion of this domain 
impairs SG assembly (Tourrière et al., 2003). An analogous process was shown for the 
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protein Staufen, which multimerizes by binding dsRNA, but also via protein-protein 
interactions (Martel et al., 2010). Staufen, G3BP and many others serve as scaffolds, and 
many of these scaffold proteins also interact with multiple stress granule components. 
Moreover, the cytoskeleton and associated motor proteins also contribute to the assembly and 
disassembly of SGs. The microtubule network destabilizing drug nocodazole reduces the 
appearance of SGs dramatically (Ivanov et al., 2003, Kwon et al., 2007) and dynein and 
kinesin motorproteins can be localized in SGs and facilitate their assembly (Loschi et al., 
2009). Disassembly of SGs occurs by exit of the mRNA from the stress granule and entry 
into translation. Translation shows an inverse relationship with the formation of SGs 
(Kedersha et al., 2000). If the translation levels increase, the number of granules drops. The 
turnover of scaffolding SG proteins may be another way to disassemble SGs. This is 
suggested by the finding that the inhibition of the ubiquitin-proteasome pathway with MG132 
induces SGs, a condition that may, however, have been caused by the activation of GCN2 
kinase (Mazroui et al., 2007). 
 
1.3.3 G3BP 
The stress granule component G3BP was first described in 1996 as a protein that binds the 
SH3 domain of Ras-GAP (Parker et al., 1996) and is known to be involved in several 
signalling pathways, such as Ras signalling (Parker et al., 1996, Pazman et al., 2000), c-myc 
mRNA turnover (Gallouzi et al., 1998, Tourriere et al., 2001) and NFκB signalling (Prigent et 
al., 2000). G3BP exists in two isoforms, G3BP-1 and G3BP-2, with 74% similarity in the 
amino acid sequence. G3BP-1 is encoded on chromosome 5 and G3BP-2 on chromosome 4. 
There are two splice variants (a and b) of G3BP-2. G3BP-2b lacks 33 amino acids in the 
proline-rich region (Kennedy et al., 2001). G3BP-1 contains 466 aa and has a predicted size 
of 52 kDa, but the electrophoretic mobility is lower. The two G3BP proteins have structural 
similarities, with four distinctive regions (depicted in Fig. 3). The N-terminus was shown by 
sequence homology to consist of a nuclear transport factor 2 (NTF2)-like domain (Suyama et 
al., 2000). The cytoplasmic protein nuclear transport factor 2 (NTF2) enables protein 
transport into the nucleus by binding to FxFG repeat motifs in proteins of the nuclear pore 
(Clarkson et al., 1996) This binding is required for the NTF2-mediated transport of cargo into 
the nucleus along the RanGDP/GTP gradient. NTF2 and its bound cargo associate with 
RanGTP and translocate to the nucleus, whereas the exchange to GDP releases the cargo and 
leads to back-transport of NTF2 to the cytoplasm (Ribbeck et al., 1998). While there is 
evidence that G3BP is targeted to the nucleus and to the nuclear envelope (Prigent et al., 
2000). G3BP apparently does not function as a nuclear transport factor: an inhibitor of 
nuclear export, leptomycin B (Ullman et al., 1997), does not affect the subcellular 
localization of G3BP (Prigent et al., 2000). Furthermore Ran is not associated with G3BP 
(Tourrière et al., 2003). Rather, the NTF2-like domain of G3BP is probably involved in 
dimerization (Suyama et al., 2000, Tourriere et al., 2001), but little is known about the 
functional consequences of such dimerization. In the centre of G3BP, there are conserved 
  15 
acidic and proline-rich regions (PxxP), which have been suggested to bind SH3 domains and 
were shown to interact with Ras-GAP (Parker et al., 1996). However, another report 
questions the concept that G3BP interacts with Ras-GAP (Annibaldi et al., 2011). 
The C-terminus of G3BP contains an RNA-recognition motif (RRM), which forms a three-
dimensional structure of D-helixes and E-sheets to interact with a stretch of 2–8 nucleotides 
of the RNA (Nagai et al., 1995, Kennedy et al., 2001). In addition to the RNA-binding 
function, RRMs of G3BP can interact with proteins which might alter the specificity of the 
RNA-RRM interaction (Cléry et al., 2008). Further C-terminally in G3BP, there is an 
arginine-glycine-glycine (RGG) motif, which is a sequence of closely located arginine and 
glycine residues, which is often unstructured due to the polar arginines next to the glycine 
residues. This unstructured region influences interactions with proteins and RNA (Rogelj et 
al., 2012). Additionally post-translational modifications of G3BP, for example the methyl-
ation of R435, could regulate the stability of the E-catenin mRNA in a Wnt-dependent 
manner (Bikkavilli and Malbon, 2011). G3BP was also shown to function as a helicase of 
both RNA and DNA. Interestingly, G3BP does not contain the canonical DEAD box of 
helicases (Bork and Koonin, 1993) and is thus a non-canonical ATP-dependent helicase. The 
RGG motifs may influence the RNA/DNA helicase activity of G3BP (Costa et al., 1999). 
 
Both G3BP-1 and G3BP-2 are dramatically overexpressed in human cancers such as breast, 
head, neck, colon and thyroid cancer as well as in human melanoma cell lines (Guitard et al., 
2001, Barnes et al., 2002, French et al., 2002, Oi et al., 2014). Growing evidence suggests 
that deregulated RNA processing is often associated with cell proliferation and cancer 
(Sonenberg and Gingras, 1998, Sueoka et al., 1999). The observation that G3BPs are 
specifically overexpressed in several cancers and involved in RNA metabolism makes them a 
potential target for anti-cancer therapeutics. 
Intriguingly, G3BP was also described as a binding partner of ubiquitin-specific protease 10 
(USP10), which is a deubiquitinating enzyme (DUB) (Soncini et al., 2001). Recently it has 
been shown that G3BP interacts with the first 76 N-terminal residues of USP10 (Takahashi et 
al., 2013). The deubiquitination activity of USP10 leads to the stabilization of several 
important proteins, including the autophagy regulator Beclin-1 (Liu et al., 2011), the NF-NB 
essential modulator (NEMO/IKKJ) (Niu et al., 2013) and the tumour suppressor p53 (Yuan et 
al., 2010, Oi et al., 2014). Interestingly, recent reports show that USP10 regulates p53 
activity, localization and stability by directly interacting and deubiquitinating p53 in the 
Figure 3: Schematic representation of human G3BP-1. Nuclear transport factor 2 (NTF2)-like domain, RNA-recognition 
motif (RRM), arginine-glycine-glycine motif (RGG), proline rich motif (PxxP), serine (S). For details see text. 
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cytoplasm, which is negatively regulated by G3BP (Soncini et al., 2001, Yuan et al., 2010, Oi 
et al., 2014). G3BP-1 is able to disrupt this interaction in vitro, indirectly leading to 
destabilization of p53 (Oi et al., 2014). However, an extensively described DUB for p53 is 
HAUSP/USP7, which is mainly found in the nucleus and reported to deubiquitinate p53. It is 
thought that USP10 deubiquitinates the cytoplasmic fraction of p53, whereas the nuclear 
fraction is deubiquitinated by HAUSP/USP7 (Yuan et al., 2010). Another report indicates 
that G3BP binds to the C-terminus of p53 to physically disrupt the normal p53 oligomer 
assembly or to obscure critical residues which are post-translationally modified (Kim et al., 
2007). However, it was not shown whether this interaction is direct, and therefore it may be 
mediated by USP10, binding both p53 and G3BP.  
In addition, G3BP also forms complexes with the cell cycle regulator Caprin-1, a protein 
which may regulate the transport and translation of mRNAs of proteins involved in cell 
proliferation and migration. Overexpression of Caprin-1 induces the formation of SGs and 
eIF2D phosphorylation through a mechanism that depends on its ability to bind mRNA 
(Solomon et al., 2007). 
 
1.3.4 SG and diseases 
SGs are implicated to be involved in many diseases. As described above, viruses target SGs 
because of their antiviral capabilities (Montero and Trujillo-Alonso, 2011, White and Lloyd, 
2012, Valiente-Echeverria et al., 2012). In some cancers, SGs are upregulated (Baguet et al., 
2007) and may support cancer survival (Fournier et al., 2010, Thedieck et al., 2013). It is also 
seen that SG-associated proteins like G3BP or USP10 are dysregulated in cancer (Barnes et 
al., 2002, Yuan et al., 2010). An emerging area of interest is the connection between mRNP 
granules, like SG, and degenerative diseases. Cytoplasmic granules are a pathohistological 
hallmark in neurodegenerative diseases. Recently, mutations were identified in the RNA-
binding proteins TDP-43 and FUS (Kwiatkowski et al., 2009, Vance et al., 2009). 
Interestingly these RNA-binding proteins are found in SGs as well (Parker et al., 2012, 
Daigle et al., 2013). TDP-43 and FUS interact with SG core components, and mutated forms 
have the capability to enhance the aggregation of SGs (Bosco et al., 2010, Liu-Yesucevitz et 
al., 2010). Additionally, SGs containing TDP-43 and FUS tend to be more persistent and 
larger (Baron et al., 2013, Vance et al., 2013). Therefore, these specific RNA-binding 
proteins may provide a link between SGs and neurodegeneration. 
Further, SGs also play a role in Alzheimer’s disease (Vanderweyde et al., 2012), where the 
SG components TIA-1 and TTP bind phospho-tau, which is a disease-linked pathological 
protein that forms stable insoluble protein aggregates. The aggregation of SGs could become 
pathological when the pro-aggregation state is favoured because of mutations, other disease 
processes or environmental conditions. 
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1.3.5 SG and signalling 
More and more reports show that signalling molecules are recruited to SGs. The transient 
assembly of SGs could influence several signalling pathways until the cell is adapted to stress 
or dies. Therefore SGs could be seen as signal hubs, which sequester signalling components 
to react to a state of emergency. As described above, SG-associated RNA-binding proteins 
have an LC/ID region in common, a region that is also found in signalling molecules like 
protein kinase CDPKCD, USP10, PKR and others. PKCD enhances the assembly of SGs in 
cells subjected to heat shock or sodium arsenite stress, most likely through binding to G3BP-
2 (Matsuki et al., 2013). USP10 interacts with G3BP and poly(A)-binding protein (PABP) 
and deubiquitinates and stabilizes the tumour suppressor p53, influencing apoptosis induction 
(Yuan et al., 2010, Oi et al., 2014). Knock-down of USP10 dampens the SG response and 
correlates with increased production of reactive oxygen species and increased apoptosis 
(Takahashi et al., 2013). Another protein, RACK1, an adaptor molecule that integrates cell 
adhesion polarity and motility, is also sequestered to SGs. However RACK1 does not contain 
LC/ID regions, but binds to the multisubunit eIF3, which is a core component of SGs. The 
recruitment of RACK1 to SGs inhibits stress-induced activation of the p38/JNK signalling 
pathway, which triggers apoptosis (Arimoto et al., 2008). When RACK1 is sequestered to 
SGs, it cannot act as a scaffolding protein for MTK1 (mitogen activated kinase 1), which acts 
upstream of p38 and JNK to initiate apoptosis. Therefore sequestration of RACK1 to SGs 
inhibits this signalling pathway and promotes cell survival. In addition, two important 
signalling molecules with a direct link to the detection of viral infections have been found to 
be sequestered to SGs as well. Upon IAV infection, RIG-I is sequestered to SGs-like 
structures, which were termed antiviral SGs (avSGs), and this sequestration was found to be 
critical to activate IFN genes. Furthermore PKR is also recruited to avSGs (Onomoto et al., 
2012). 
 
1.3.6 SG and viral infections 
SGs have fundamental roles in inhibition of host mRNA translation, which affects viral 
mRNAs as well. Viruses are totally dependent on the cellular gene expression machinery, and 
therefore it is evident that viruses interact with SGs to control virus replication and counteract 
antiviral effects of SGs. A very well described mechanism employed by cells to restrict viral 
propagation is through the activation of PKR. Activated PKR phosphorylates eIF2D leading 
to the formation of SGs and translational restriction. Many viruses, such as influenza virus, 
vaccinia virus, poliovirus, herpes simplex virus, West Nile and dengue virus employ 
mechanisms to avoid or block the functions of PKR and SGs (Montero and Trujillo-Alonso, 
2011, White and Lloyd, 2012, Valiente-Echeverria et al., 2012, Lloyd, 2013). Furthermore 
the formation of SGs may also lead to the sequestration of viral mRNA and eukaryotic 
initiation factors, which could limit efficient translation of viral proteins. 
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White and Lloyd reviewed the interactions between viruses and SGs and grouped them into 
three phenotypic categories, which might be revised in the future: firstly viruses that inhibit 
SGs, secondly viruses that tolerate or exploit SG responses and lastly viruses that first induce 
and then inhibit SGs. (White and Lloyd, 2012). West Nile virus and dengue virus, which 
belong to the family Flaviviridae, inhibit SG formation by sequestration of TIA-1 through 
specific binding to the minus strand 3´ terminal stem loop structure of the viral genome 
(Emara and Brinton, 2007). Dengue virus 3´ UTR and 5´ UTR physically interact with G3BP, 
Caprin-1 and USP10, as well as the PB marker DDX6 (Ward et al., 2011). These proteins 
were found to colocalize with dsRNA, which marks replication sites. IAV also fails to induce 
SGs, except for mutant viruses that lack non-structural protein 1 (NS1). In the latter case, 
infection with NS1 mutants, SGs are formed in a PKR-dependent manner. The complete 
inhibition of SG assembly is dependent on the action of NS1 on PKR (Khaperskyy et al., 
2011). The formation of SG represses IAV replication if NS1 is lacking. The induction of 
SGs is also blocked by HSV via multiple mechanisms. This highlights again the potent anti-
viral effect of SGs. Early in HSV infection, activated PKR subsequently phosphorylates 
eIF2Dwhich is dephosphorylated by the recruitment of serine/threonine protein phosphatase 
I by ICP34.5, hence re-activating translation (He et al., 1997). It was shown that HSV-1 
mutants lacking the virion host shutoff (vhs) protein, an endoribonuclease that degrades 
cellular and viral mRNA, induce SGs late in infection (Esclatine et al., 2004, Dauber et al., 
2011) A possible role for vhs might be inhibition of SGs or altering expression of other SG-
modulating viral gene products. An additional role could be the limitation of available mRNA 
which is needed to nucleate bona fide SGs. Further the closely related family member HSV-2 
also blocks the formation of SGs induced by sodium arsenite but not Pat A (Finnen et al., 
2012). 
The second category of virus/SG interplay is that viruses may tolerate or exploit the SG 
response. As described above, SGs and active virus replication do not commonly co-exist, 
because it appears that SGs have a negative effect on viruses and are selected against. 
However, it is possible that some viruses co-opt or misdirect the SG response for their favour, 
meaning that SGs have a positive effect on viral replication in this case. For instance, VV 
sequesters SG proteins into novel aggregates comprised of G3BP, Caprin-1, eIF4G and 
eIF4E (Katsafanas and Moss, 2007, Simpson-Holley et al., 2011), but surprisingly no 
silenced cellular mRNA, instead, they contain viral mRNA. The structures are found in close 
proximity to viral replication factories and may help VV to segregate replication and 
packaging away from translation (Simpson-Holley et al., 2011).  
The third group includes viruses which first induce the formation of SGs, but later 
disassemble them and inhibit their reformation. Poliovirus for example induces the formation 
of SGs in an eIF2D-independent manner (White et al., 2007). The formation of SGs peaks 2–
3 hours post infection and then declines, by a mechanism that requires viral replication 
(White et al., 2007). When exogenous stressors (such as sodium arsenite) are applied, the 
formation of bona fide SGs is inhibited in poliovirus infected cells. However in another 
report, TIA-1-positive SGs were observed late in poliovirus-infection (Piotrowska et al., 
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2010), They were later identified as non-canonical SGs because they lacked SG-defining 
components like initiation factors and mRNA (White and Lloyd, 2011). The mechanism how 
poliovirus disassembles SGs resides in the activity of the viral protease 3Cpro, which cleaves 
G3BP. When a cleavage-resistant mutant of G3BP (Q326E) is expressed, the formation of 
SGs is rescued, along with a sevenfold decrease in viral replication, which also indicates the 
potential antiviral role of SGs (White et al., 2007, White and Lloyd, 2011). Another virus 
which first induces SGs and then inhibits their formation is hepatitis C virus. It has been 
shown that several SG markers colocalize with the HCV core protein, which is likely 
mediated by the interaction of G3BP and maybe other factors with the viral protein NS5B 
and the 5´ terminus of the negative-strand RNA (Yi et al., 2011, Khong and Jan, 2011). SFV 
modulates the SG response as well. At early times of infection, SFV induces the 
phosphorylation of eIF2D in a PKR-dependent manner and promotes the formation of SGs. 
Despite the shutoff of host protein synthesis, viral mRNA is still translated due to a 
translational enhancer, which efficiently works in conditions where eIF2α is phosphorylated. 
Later in infection, the SGs are disassembled, and the infected cell is not responsive to 
exogenous stress. This is supported by the observation that areas around the viral RNA are 
devoid of SGs, which also indicates that viral proteins or RNA may locally disassemble SGs 
to favour viral replication (McInerney et al., 2005). 
The aims of this thesis were to determine how SFV disassembles SGs and what consequences 
develop from the disassembly. Furthermore we asked if the closely related CHIKV 
disassembles SGs with a similar mechanism. Lastly we investigated the molecular nature of 
the SFV-mediated SG disassembly. 
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1.4 AIMS OF THE THESIS 
 
The overall aim of this thesis was to study virus-host cell interactions in SFV-infected cells.  
Paper I  
In paper I we addressed the question how SFV achieves the disassembly of SGs very early in 
infection and how cells are still able to react to other stresses. 
Paper II 
In paper II we asked whether the closely related alphavirus CHIKV also induces disassembly 
of SGs in a similar fashion as SFV. Furthermore is this interaction direct or mediated by other 
factors. 
Paper III  
In paper III we sought to investigate in molecular detail how the viral protein nsP3 binds 
G3BP. We further asked whether other cellular and viral proteins use the same mechanism as 
nsP3 and lastly if this interaction inhibits the formation of SGs. 
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2 RESULTS 
It has been shown in SINV-infected cells that G3BP interacts with nsP3 (Cristea et al., 2006). 
Nevertheless it was also reported that G3BP interacts with nsP2 (Atasheva et al., 2007) and 
nsP4 (Cristea et al., 2010), therefore it is not clear if nsP3 is the direct interacting partner of 
G3BP. Furthermore, G3BP is a defining component of SGs and targeted by other viruses to 
inhibit the formation of SGs. The poliovirus 3Cpro protease cleaves G3BP to inhibit the 
formation of SGs (White et al., 2007). Therefore we hypothesized in SFV-infected cells, 
G3BP is sequestered to viral replication complexes, which might explain an earlier report by 
our group showing that regions in the cell in the vicinity of the viral RNA are devoid of SGs 
(McInerney et al., 2005). Further the sequestration of G3BP may inhibit SG reformation in 
infected cells. To assess this, we performed immunofluorescence experiments on SFV 
infected mouse embryonic fibroblasts (MEF). Interestingly we observed a strong 
colocalization of G3BP with the viral protein nsP3 at 8 hours post infection (hpi) (Fig. 4A, 
Paper I Fig. 1B). To determine if these foci are viral replication complexes, we stained 
infected cells against G3BP, nsP1 and dsRNA and confirmed that the foci were positive for 
G3BP, nsP1 and dsRNA (Paper I Fig. 1C). Other cellular interaction partners of G3BP, like 
USP10 or Caprin-1, were excluded from these foci (Paper III Fig. S3, and data not shown). 
We then infected baby hamster kidney (BHK) cells to determine whether nsP3 interacts with 
G3BP. At 8 hpi, lysates were immunoprecipitated with G3BP or nsP3 antisera and probed for 
nsP3, G3BP-1 and actin. G3BP-1 was coimmunoprecipitated with nsP3 and vice versa (Fig. 
4B, Paper I Fig.1A). This suggests that nsP3 forms a complex with G3BP and sequesters it 
into viral replication complexes.  
Figure 4: SFV forms a complex with G3BP and sequesters it into viral replication complexes. (A) MEF cells were
infected with SFV-wt at an MOI of 1 for 8 h, fixed and stained for nsP3 and G3BP-1. Bar 10 μm. (B) BHK cells were
infected at an MOI of 10 with SFV-wt. Cell lysates were prepared 8 hpi and immunoprecipitated (IP) with nsP3- or G3BP-
antisera and probed for nsP3, G3BP-1 or actin. The position of the heavy chain (HC) is indicated. 
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Next, we sought to investigate if nsP3 is the sole interacting partner of G3BP and or if this 
interaction is mediated by one of the other non-structural proteins and asked what motifs in 
nsP3 interact with G3BP. At the C-terminal part of nsP3, two seven amino acid repeat 
sequence elements, L/ITFGDFD (here referred to as C-terminal repeat domain), conserved in 
the Old World alphaviruses, were identified by Varjak and colleagues (Varjak et al., 2010). 
The two C-terminal repeat domains are separated by a stretch of 10 amino acids (“spacer”). 
To biochemically assess if nsP3 is the sole SFV protein to interact with G3BP and to map the 
interaction domain, we generated two nsP3 mutants for use in transfection experiments in the 
absence of infection, hence potentially excluding a contribution of the other viral proteins. 
nsP3-'10 lacks 10 amino acids of the non-conserved C-terminal region and nsP3-'30 
lacking 30 amino acids of the C-terminus, including the C-terminal repeat domains. In paper I 
(Fig. 2A) we showed in cells expressing individual nsP3-wt and nsP3-'10 interacted with 
G3BP, confirming that indeed, nsP3 is the sole viral interaction partner for G3BP. 
Furthermore, the nsP3-'30 mutant did not, suggesting that the interaction is mediated by 
sequences within the C-terminal 30 aas. Interestingly a stretch of 31 amino acids containing 
the two C-terminal repeat domains of nsP3 fused to GFP (EGFP-nsP3-31) efficiently 
coimmunoprecipitated G3BP (Paper I Fig. 2B). These findings led to the creation of virus 
mutants with similar truncations in nsP3. The truncation SFV-'8 lacks 8 amino acids of the 
spacer region. SFV-'78 lacks the spacer region and the first C-terminal repeat, and SFV-
'789 lacks both C-terminal repeats (Fig. 5A, Paper I Fig. 3A). We infected BHK cells with 
wildtype (wt) SFV (SFV-wt) or the virus mutants and lysates were subjected to 
immunoprecipitation with G3BP antisera, followed by Western blot for nsP3, G3BP and 
actin. nsP3-wt was efficiently coimmunoprecipitated by G3BP, as expected. nsP3 from the 
virus mutant SFV-Δ8, also coimmunoprecipitated with G3BP, but less efficiently. SFV-Δ78, 
lacking the 8 amino acid of the spacer region as well as the first C-terminal repeat showed a 
drastically reduced interaction with G3BP. Whereas the viral mutant (SFV-Δ789), lacking the 
both repeats in nsP3 did not coprecipitate G3BP (Fig. 5B, Paper I Fig. 3B). Single-step and 
multistep growth curve experiments revealed that the virus mutant SFV-Δ789 is attenuated 
for growth in both MEF cells (Fig. 5C, Paper I Fig 3C) and BHK cells (Paper I Fig. S2). 
Taken together these results show that nsP3 is the sole SFV protein to interact with G3BP. 
Furthermore, the two C-terminal repeats of nsP3 are necessary to interact with G3BP and that 
a virus mutant, lacking these, is limited in viral propagation. 
 
 
 
 
 
 
  23 
 
At the same time, Fros and colleagues (Fros et al., 2012) also showed, that nsP3 colocalizes 
with G3BP, using CHIKV-infected Vero cells. Their results however suggest that the proline-
rich region, spanning residues 398–406 of nsP3, is essential for colocalization of CHIKV-
nsP3 and G3BP. This is in contrast to our work and it is unexpected that two Old World 
alphaviruses would differ in the region to bind G3BP. In Paper II, we hence addressed the 
question if the proline-rich sequence and the C-terminal repeat domains are both necessary to 
colocalize and interact with G3BP. Immunostaining of MEF cells, infected with the SFV-
'P1+P2 virus mutant that lacks the proline-rich sequence in nsP3 (Neuvonen et al., 2011), 
revealed colocalization of nsP3 and G3BP (Paper II Fig. 1A). Furthermore, in transfection 
experiments with SFV-nsP3-'P1+P2 and CHIKV-nsP3-'P1, lacking the proline-rich 
sequences, the nsP3 mutants efficiently coprecipitated G3BP (Fig. 6B, Paper II Fig. 1C). 
Additionally, Vero cells transfected with CHIKV-nsP3-'398–406 efficiently colocalized and 
coprecipitated G3BP confirming that the proline-rich region is not required for the interaction 
of CHIKV-nsP3 with G3BP (Paper II Fig. 3B and C). We conclude from these results that the 
G3BP binding site in nsP3 of the Old World alphaviruses SFV and CHIKV resides in the C-
terminal repeats of nsP3 and that the proline-rich region is not required for the interaction.  
 
 
 
 
Figure 5: The C-terminal repeats of SFV-nsP3 are required for sequestration of G3BP-1. (A) Representation of the C-
terminal sequences of nsP3 from SFV-wt, -Δ8, -Δ78 and -Δ789. The C-terminal repeats are shown in bold. (B) BHK cells
were infected with the indicated viruses at an MOI of 10. Cell lysates were prepared at 8 hpi and subjected to
immunoprecipitation (IP) with G3BP-1 antisera. Lysates and IPs were probed for the indicated proteins. (C) BHK cells were
infected at an MOI of 0.1. At 4, 8, 12, 24 and 38 hpi, supernatants were collected and SFV infectious units were quantified by
plaque assay on BHK cells. Error bars indicate SD of two independent experiments. 
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Previous studies have shown that after 8 h of infection with SFV, cells are not capable of 
forming SGs in response to exogenous stress such as sodium arsenite (McInerney et al., 
2005). The work presented here suggests that a possible mechanism to block SGs is the 
sequestration of G3BP to nsP3-containing replication complexes. Thus we asked whether 
cells respond to exogenous stress and form SGs if G3BP is sequestered to replication 
complexes. Therefore we infected cells with SFV-wt or the mutant SFV-Δ789 for 7 h and 
subsequently treated the cells for 1 h either with sodium arsenite or Pat A. The cells were 
fixed and stained for G3BP-1 and TIA-1 and the number of SGs positive cells was evaluated. 
We used Pat A because sodium arsenite signals through eIF2D phosphorylation, which does 
not have an effect in in SFV-infected cells due to sustained high levels of infection-induced 
phospho-eIF2D. Pat A on the other hand is an eIF2D-independent stress and stalls translation 
by interacting with the helicase eIF4A (Bordeleau et al., 2006). As expected, SFV-wt infected 
cells were not able to mount a stress response to exogenous stressors such as sodium arsenite 
or Pat A. On the other hand SFV-'789 did not mount a stress response upon sodium arsenite 
treatment but mounted a significant stress response upon Pat A treatment (Fig 7, Paper I Fig. 
6B). This shows that SFV has an active mechanism to dissolve SGs and to block their 
reformation on viral mRNA later in infection.  
Figure 6: Proline-rich sequences of SFV and CHIKV nsP3 are not required for G3BP-1 binding. (A) Extreme C-
terminal sequences of SFV-nsP3-wt, nsP3-'P1+P2, nsP3-'C, and CHIKV-nsP3-wt and nsP3-'P1. (B) BHK cells were 
mock-transfected or transfected with the indicated constructs. The nsP3 proteins were tagged with a biotin acceptor 
peptide (BAP). Cell lysates were prepared, precipitated with streptavidin-coated beads and probed with the indicated 
antibodies. 
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Interestingly, experiments with cells expressing nsP3 alone indicated that nsP3 on its own 
does not have the capacity to block the formation of SGs. In colocalization studies, we 
showed that cells expressing nsP3 in the absence of the other viral proteins and stressed with 
Pat A formed SGs and that nsP3 was found in SGs along with G3BP-1 and TIA-1 (Paper I 
Fig. 7A). However, experiments with the polyprotein nsP123 revealed that the formation of 
CPV-like structures containing nsP1, nsP2 and nsP3 was able to block SGs and that nsP3 was 
not found in bona fide SGs under stress conditions (Paper I Fig. 7B). Taken together, these 
results show that the formation of CPV-like structures and the interaction of these with G3BP 
is necessary to block the assembly of SGs. 
We next sought to determine if the binding of nsP3 to G3BP is direct and if so which amino 
acids mediate this binding. In paper II we purified the His-tagged protein of the NTF2-like 
domain of G3BP-1 (His-G3BP1-NTF2) and the 31 aa of the C-terminus of nsP3 fused to 
GST (GST-31) expressed in E. coli. We showed in in vitro binding studies that GST-31 
efficiently binds His-G3BP1-NTF2, but not GST alone. This verifies that the interaction is 
direct and not mediated by cellular or viral proteins. Furthermore the His-G3BP1-NTF2 
construct lacks the RNA-binding domain of G3BP. It can hence be concluded that RNA is 
not involved in the nsP3-G3BP binding either (Paper II Fig. 4C). To investigate which amino 
acids mediate binding of nsP3 to G3BP, we performed an alanine scan of the C-terminal 
repeats. We used the EGFP-nsP3-31 construct created for paper I and replaced each of the 
amino acids 2–7 in both C-terminal repeats (L/I1T2F3G4D5F6D7) consecutively with alanine 
(Fig. 8A, Paper III Fig. 1A). We then transfected BHK cells with these constructs followed 
by cell lysis, immunoprecipitation with GFP antisera and probed for G3BP. The results (Fig. 
8B, Paper III Fig. 1B) clearly show that the mutation of the phenylalanines at positions 3 and 
6 of the motif to alanines disrupted the binding to G3BP. Also the mutation of glycine 4 
destroyed the interaction. The mutation of the aspartate residue at position 5 and threonine at 
position 2 led to a drastically reduced binding. In summary, these data reveal a core G3BP-
Figure 7: G3BP-1 sequestration into SFV RCs inhibits Pat A- induced SGs. MEFs were infected with SFV-wt, SFV-
Δ789 or SFV-F3A at an MOI of 50 for 7 h before 1 h treatment with sodium arsenite or pateamine A. Cells were fixed and 
stained for G3BP-1, TIA-1 and nsP3. Fifty cells per treatment were scored SG+ based on G3BP-1 and TIA-1 colocalization. 
Data are presented as mean +/- SD from three independent experiments. Student’s t test: * < 0.05, ** < 0.001. 
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binding motif of FGDF in nsP3, in which the residues F3, G4 and F6 are essential. 
Furthermore there is a strong preference for threonine at position 2 and for aspartic acid at 
position 5.  
 
Based on the alanine scanning experiments of the C-terminal repeats we created an infectious 
clone of SFV (referred to as SFV-F3A) where the residues F451 and F468 in the two C-
terminal repeats were exchanged to alanines (Fig. 9A), to test if the phenylalanines at position 
3 are essential for binding of nsP3 to G3BP in the context of virus infection. Infection 
experiments with SFV-F3A revealed that, in contrast to SFV-wt, G3BP did not colocalize 
with nsP3 nor coprecipitate with nsP3 (Fig. 9B, Paper III Fig. 2A and B). Moreover, cells 
infected with SFV-F3A were able to respond to exogenous stress induced by treatment with 
Pat A (Fig. 7, Paper III Fig. 2C), while SFV-wt-infected cells were not. Finally, the F3A 
mutant virus was attenuated for growth in MEF and BHK cells (Fig. 9C, Paper III Fig. 2D 
and S2) to a similar extent as SFV-'789 (Fig. 5C). This demonstrates that the sequestration 
of G3BP to replication complexes by the FGDF motifs of nsP3 inhibits the SG response and 
is important for the efficient replication of SFV.  
 
 
 
Figure 8: Mutagenesis of the G3BP-binding domain in SFV-nsP3 reveals a core binding motif of FGDF. (A) C-terminal
sequences of pEGFP-C1, pEGFP-nsP3-31-wt, -T2A, -F3A, -G4A, -D5A, -F6A or -D7A. Alanine mutations are shown in 
bold. (B) BHK cells were mock-transfected (M) or transfected with pEGFP-nsP3-31-wt, -T2A, -F3A, -G4A, -D5A, -F6A, -
D7A or pEGFP-C1. Cell lysates were prepared 16 h after transfection and immunoprecipitated (IP) with anti-GFP. Lysates
and IPs were probed for G3BP-1, GFP or actin. 
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Earlier we showed that G3BP was recruited to replication complexes in SFV infected cells; 
however the G3BP interaction partner USP10 was not (Paper III Fig. S3). This suggests that 
USP10 is excluded from the complex with G3BP by the nsP3/G3BP interaction, proposing a 
competition of nsP3 and USP10 for G3BP. Sequence analysis showed that USP10 also 
contains an FGDF motif, which is situated at the N-terminus (Paper III Fig. 3A). We 
hypothesized that the FGDF motif of USP10 interacts with G3BP in a similar fashion as 
described above for nsP3. It has been shown that G3BP interacts with the first 76 N-terminal 
residues of USP10 (Takahashi et al., 2013). To test this experimentally, we fused the N-
terminal 40 amino acids of USP10 to GFP, transfected cells, performed immunoprecipitations 
with GFP antisera and blotted for G3BP. Indeed, G3BP was found to interact with the N-
terminal region of USP10 (Paper III Fig. 3B). Further, alanine mutations which replace F10, 
G11 or F13 disrupted the interaction with G3BP, strikingly similar to nsP3. This strongly 
suggests that G3BP binding of USP10 is also mediated by an FGDF motif (Paper III Fig. 
3C). Interestingly the overexpression of full-length USP10, fused to GFP, had the capacity to 
block the formation of SGs induced by exogenous stress, whereas a non-interacting GFP-
USP10-F10A failed to do so (Paper III Fig. 3D). Taken together, these data suggest that GFP-
USP10 acts as a negative regulator of SG formation by binding G3BP via an FGDF motif. 
In addition we hypothesized that G3BP may have other binding partners that also use FGDF 
motifs. Alignments of USP10 proteins from different species and alignments of the nsP3 
sequences of different Old World alphaviruses suggested that the aspartate residue at position 
5 in the FGDF motif (numbering of the motif: L/I1T2F3G4D5F6D7) can be replaced by a serine 
or a glutamate. We also noted that the FGDF motifs of USP10 and nsP3 are followed by at 
least two acidic residues within the downstream four residues. In order to identify candidates 
which might bind G3BP, a bioinformatic query for the following motifs F-G-[DES]-F-[DE], 
F-G-[DES]-F-X-[DE], F-G-[DES]-F-X-X-[DE], F-G-[DES]-F-X-X-X-[DE], F-G-[DES]-F-
X-X-X-X-[DE] (X = any aa) in human and viral proteins in the UniProt database was 
performed. We identified 34 human proteins and 32 viral proteins (Paper III Tables S1 and 
Figure 9: The C-terminal repeat domains of SFV-nsP3 are required for sequestration of G3BP-1. (A) Representation of
the C-terminal sequences of nsP3 from SFV-wt and -F3A. The C-terminal repeats are shown in bold, whereas the F3A
mutation is shown in bold. (B) BHK cells were infected with the indicated viruses at an MOI of 10. Cell lysates were
prepared at 8 hpi infection and subjected to immunoprecipitation with G3BP-1 antisera. Lysates and IPs were probed for the 
indicated proteins. (C) BHK cells were infected at an MOI of 0.1. At 4, 8, 12, 24 and 38 hpi supernatants were collected and 
SFV infectious units were quantified by plaque assay on BHK cells. Error bars indicate SD of two independent experiments. 
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S2) that contain an FGxF (x = D, E, S) and may bind G3BP. One of these is the major DNA-
binding protein (also referred to as ICP8) of HSV that contains an FGDF motif in an 
unstructured region at the C-terminal end. In order to determine if ICP8 is capable of forming 
a complex with G3BP, we cotransfected cells with ICP8 and EGFP-G3BP, performed 
immunoprecipitation with GFP antiserum and blotted for ICP8. As predicted, ICP8 also 
interacted with G3BP (Paper III Fig. 7A). In addition, overexpression experiments with ICP8 
revealed, similarly to the USP10 overexpression experiments (Paper III Fig. 3D), that the 
cytoplasmic fraction of ICP8 harbours the ability to block the formation of SGs induced by 
exogenous stress (Paper III Fig. 7B). This indicates that ICP8 can act, similarly to USP10, as 
a negative regulator of the formation of SGs by binding to G3BP via its FGDF motif. A 
function for the cytoplasmic fraction of ICP8 in SG disassembly has not been described yet. 
The NTF2-like domain of G3BP in complex with an FxFG-containing peptide has been 
recently crystallized (Vognsen et al., 2013). The FxFG peptide shows similarities to the 
FGDF motif found in nsP3, USP10 and ICP8 and is bound into a hydrophobic cleft on the 
surface of G3BP. Based on that structure, we modelled an FGDF-containing peptide into the 
same hydrophobic cleft of G3BP (Fig 10, Paper III Fig 5 A and B). 
 
According to this model, there is a deep pocket at the base of the hydrophobic cleft formed by 
F15, F33 and F124, where the side chain of F3 is buried. A shallower pocket is formed by 
Figure 10: Molecular model of G3BP/FGDF interaction. (A) Ribbon representation of the G3BP-NTF2 with the manually
docked LTFGDFDE peptide. The N-terminal 11 residues of the protein as well as several residues lining the peptide-binding
groove are displayed as grey sticks. The LTFGDFDE peptide is displayed as sticks with yellow carbon atoms, residues are
labelled in red. Residues of G3BP are labelled in black. 
DI EII 
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F124, V11 and L10, where the side chain of F6 is localized. Both phenylalanines of the 
FGDF motif point into these two pockets. This binding model, presented in paper III Fig. 5, 
led to the prediction that the phenylalanine F33 is important for FGDF binding. To 
experimenttally validate the model we performed site-directed mutagenesis of the 
hydrophobic cleft in G3BP (Fig. 11A, Paper III Fig. 6A). The F33 residue, which is proximal 
to the F3 in the L/I1T2F3G4D5F6D7 peptide, was mutated to the bulkier tryptophan to make the 
hydrophobic cleft smaller and to introduce steric hindrance. As a control we mutated F124 
also to tryptophan, because this residue is not located in the binding cleft and is also solvent-
accessible. To test the proposed binding model, we cotransfected cells with nsP3 (tagged with 
a biotin acceptor peptide (BAP)) and either with EGFP-C1, EGFP-G3BP-wt, -F33W or -
F124W. Cell lysates were subjected to immunoprecipitation with GFP antisera and blotted 
for nsP3, GFP, or actin (Fig. 11B, Paper III Fig. 6B). EGFP-G3BP-wt interacted with nsP3, 
as expected. The mutant EGFP-G3BP-F124W also interacted with nsP3, whereas EGFP-
G3BP-F33W did not. Importantly, similar experiments with the HSV protein ICP8 (Paper III 
Fig. 7A) showed analogous results, as well as experiments with endogenous USP10 (Fig. 
11C, Paper III Fig. 6C). The combination of these results shows a striking similarity, which 
strongly supports our model how FGDF motif-containing proteins bind to G3BP. 
  
Figure 11: Site-directed mutagenesis in the FGDF peptide binding cleft of G3BP. (A) Schematic representation of the
G3BP-F33W mutant (upper panel) and the G3BP-F124W mutant (lower panel) with the modelled LTFGDFDE peptide. The 
peptide is displayed as sticks with yellow carbon atoms. Mutated tryptophan residues are shown in magenta. (B) HEK293T
cells were mock-transfected or cotransfected with pEBB/PP-SFV-nsP3 (nsP3-BAP) and either pEGFP-C1, pEGFP-G3BP-wt,
-F33W or -F124W. Cell lysates were prepared 24 h after transfection and subjected to immune-precipitation with anti-GFP.
Lysates and IPs were probed with streptavidin-HRP (nsP3) or antibodies against GFP or actin. (C) HEK293T cells were
mock-transfected or transfected with pEGFP-C1, pEGFP-G3BP1-wt, -F33W or -F124W. Cell lysates were prepared 24 h
after transfection and immunoprecipitated with GFP antisera. Lysates and IPs were probed for USP10, GFP or actin 
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3 DISCUSSION 
In this thesis we showed that the SFV and CHIKV nsP3 proteins directly bind G3BP. 
Complex formation of G3BP with nsP3 has been observed previously (Cristea et al., 2006, 
Frolova et al., 2006, Gorchakov et al., 2008), but we are the first to show that this interaction 
is direct and to describe it in molecular detail. The interaction is mediated by two C-terminal 
repeats of nsP3 (Paper I and II). These repeats are conserved in nsP3 of the Old World 
alphaviruses but not in the New World alphaviruses. Accordingly, nsP3 of the New World 
alphavirus VEEV does not colocalize with G3BP (Foy et al., 2013). In Paper III we 
investigated the binding sequences in molecular detail and found that the binding of nsP3 to 
G3BP is mediated by FGDF motifs (numbering of the motif L/I1T2F3G4D5F6D7). An alanine 
scan revealed that the amino acids F3, G4 and F6 of the FGDF motif are necessary to bind 
G3BP. This interaction leads to sequestration of G3BP to replication complexes, as 
confirmed by staining for nsP1 and dsRNA. These results also revealed that the cellular 
interaction partners of G3BP, USP10 and Caprin-1 are excluded from the replication 
complexes. We show that like nsP3, USP10 also contains an FGDF motif that mediates 
binding to G3BP (Paper III). This suggests that USP10 and nsP3 bind to G3BP in the same 
manner and thus compete for the binding site, thus explaining the exclusion of USP10 from 
the viral replication complexes. It was reported that Caprin-1 interacts with the NTF2-like 
domain of G3BP via a conserved peptide motif spanning amino acid 372–380 (Solomon et 
al., 2007). Interestingly, Vognsen and colleagues modelled this peptide into a binding cleft of 
G3BP which lies between the D1 helix and the EII sheet (Fig 10), thus besides the FGDF-
binding site (Vognsen et al., 2013). This implies that Caprin-1 does not compete directly with 
the FGDF binding site on G3BP. Yet, immunoprecipitation experiments revealed that Caprin-
1 efficiently coprecipitated with G3BP but not USP10 while USP10 efficiently coprecipitated 
with G3BP but not Caprin-1 (Nancy Kedersha, Harvard Medical School, personal 
communication) suggesting that there are two complexes present in the cell, G3BP/USP10 
and G3BP/Caprin-1, but no ternary complex G3BP/Caprin-1/USP10. It is plausible that 
FGDF-mediated binding (of USP10 or nsP3) changes the conformation of G3BP to exclude 
Caprin-1 from the complex, which may be the reason why Caprin-1 is not found in the 
G3BP/USP10 complex or the viral replication complexes. 
As we showed in paper I, SFV-nsP3 binds G3BP via two C-terminal repeats (comprising 
FGDF motifs as shown in paper III) sequesters it into replication complexes and in doing so 
inhibits the assembly of SGs. Another report by Fros and colleagues (Fros et al., 2012) 
presented that the closely related virus CHIKV also recruits G3BP to replication complexes 
and blocks SGs. In that study however, the G3BP-interacting domain was mapped to the 
proline-rich domain of nsP3. This domain had previously been shown to interact with 
amphiphysins (Neuvonen et al., 2011). The proline-rich domain and the C-terminal repeats in 
the hypervariable domain (HVD) of nsP3 are well conserved in the Old World alphaviruses, 
and therefore it is surprising that the two viruses should differ in the region used for recruiting 
G3BP. Fros and colleagues showed in transfection experiments that G3BP does not 
colocalize with an nsP3 construct missing the proline-rich domain. On the other hand, in our 
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work, transfection experiments using mutants of SFV and CHIKV nsP3 lacking the proline-
rich region presented in paper II showed that G3BP strongly colocalized in nsP3-positive 
foci. Biochemical analysis revealed that G3BP is efficiently coprecipitated with nsP3 that 
lacks the proline-rich sequences. Nevertheless an nsP3 mutant which lacks both the proline-
rich sequence and two C-terminal repeats did not colocalize or coprecipitate with G3BP. 
Interestingly amino acid sequences derived from the C-terminal part of SFV- and CHIKV-
nsP3, containing the C-terminal repeats but not the proline rich region, efficiently 
coprecipitated G3BP, suggesting that the C-terminal repeats are necessary and sufficient to 
bind G3BP. Recently published work with VEEV and chimeric SINV virus showed that the 
HVD domain of VEEV nsP3, containing a proline-rich sequence but not the two C-terminal 
repeats, does not form a complex with G3BP thus supporting our findings (Foy et al., 2013). 
In summary the work from Fros and colleagues showed that the sequestration of G3BP to 
CHIKV replication complexes inhibits the formation of SG as we have reported in paper I for 
SFV. However we showed in paper II that that the described CHIKV-nsP3 proline-rich 
sequence is unnecessary for recruiting G3BP to CHIKV replication complexes. Furthermore 
our results in paper III indicate that nsP3 proteins of the Old World alphaviruses bind G3BP 
via their FGDF motifs, whereas the New World alphavirus nsP3 does not interact with G3BP. 
In this thesis, we present data that show that the FGDF domain of SFV-nsP3, CHIKV-nsP3 
and USP10 are essential and sufficient to bind G3BP. We noted from alignments of USP10 
from different species and alignments of the Old World alphavirus nsP3 sequences suggested 
that the aspartate in the FGDF motif could also be a glutamate or a serine, which leads to the 
description of an FGxF core motif to bind G3BP. We also noticed that the FGDF motifs of 
SFV-nsP3 and USP10 are followed by at least two acidic residues within the downstream 5 
residues. A bioinformatic search revealed 34 human proteins and 32 viral proteins containing 
such FGxF motifs. Biochemical analysis conducted for one of these, the HSV-1 protein ICP8, 
showed that it is indeed capable of interacting with G3BP, which hasn´t been reported yet. 
Even though ICP8 is a predominantly nuclear protein during HSV-1 infection, a sizeable 
fraction of the protein remains in the cytoplasm (Knipe and Spang, 1982), but functions for 
the cytoplasmic fraction are not well described. Our results suggest that the cytoplasmic 
fraction of ICP8 has the potential to inhibit SG assembly or alter other functions of G3BP. 
HSV infection blocks the induction of SGs via multiple mechanisms, also highlighting the 
potent anti-viral effect of SGs (see introduction chapter 1.3.6). ICP8-G3BP interaction may 
represent another mechanism by which HSV infection blocks SG formation. This needs to be 
determined in the context of HSV infection. 
On the basis of our biochemical data on the FGDF-mediated binding of nsP3, USP10 and 
ICP8 to G3BP, we created a molecular model and manually docked the octapeptide 
L1T2F3G4D5F6D7E8 peptide into a hydrophobic cleft of G3BP. The NTF2-like domain of 
G3BP was crystallized and described by Vognsen and colleagues to bind a DSGFSFGSK 
peptide derived from nucleoporins (Vognsen et al., 2013). Our model shows that both 
phenylalanines fit snugly into the G3BP binding cleft and that the glycine at position 4 
ensures flexibility in the motif such that the phenylalanines point in the same direction. 
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Interestingly the aspartate at position 5 may form a salt bridge with K123 of G3BP. The 
model presented in paper III also allows predictions how to disturb the interaction by 
mutating G3BP. The amino acid F33 of G3BP is the closest amino acid to the first 
phenylalanine of the FGDF motif. F33 is buried at the bottom of the hydrophobic cleft and 
we hypothesized that a mutation to a tryptophan would make the pocket smaller and therefore 
inhibit binding. As a control, we mutated F124 to a tryptophan since this residue is not part of 
the hydrophobic cleft. Immunoprecipitation experiments with a mutant carrying the F33W 
mutation clearly showed the loss of binding of nsP3, USP10 and ICP8, whereas the F124W 
mutant still bound all three proteins. This confirms our three-dimensional model, presented in 
paper III; it provides a deep structural understanding of the interaction of the G3BP/FGDF 
complex and could give insights how to design specific drugs to target this interaction. 
Several RNA viruses transiently induce SGs. Early in the replication of such viruses, dsRNA 
is generated which leads to the activation of PKR and subsequent phosphorylation of eIF2D. 
This phosphorylation induces the assembly of SGs on abortive translation complexes. 
Poliovirus for example induces SG assembly early in infection; however the signals for the 
induction are less clear. Later in infection the SGs are efficiently disassembled by the 
cleavage of G3BP, mediated by the viral protease 3Cpro. This was nicely confirmed using a 
non-cleavable version of G3BP, the expression of which led to a significant reduction in titre 
(White et al., 2007). West Nile virus and dengue virus, which belong to the family of 
Flaviviridae, recruit the SG protein TIA-1 to viral replication sites, which leads to the 
inability to respond to exogenous stress and to a block of SG formation (Emara and Brinton, 
2007). SFV induces the formation of SGs early in infection and during the course of infection 
they are disassembled in the vicinity of replication complexes (McInerney et al., 2005). In 
paper I we presented that nsP3 interacts with G3BP. Deletions of the C-terminal repeat 
domains of nsP3 or the introduction of two single point mutations F451A and F468A in nsP3 
led to two virus mutants which were not able to form a complex with G3BP. Experiments 
confirmed that the mutants were delayed in the disassembly of SGs compared to SFV-wt. 
Furthermore, both viruses SFV-'789 and SFV-F3A were attenuated in growth by 1.5 to 2 
logs in titre (Papers I and III). Additionally, cells infected with the mutant viruses were able 
to react to exogenous stress, whereas cells infected with SFV-wt were not (Papers I and III). 
Also infections with viral vectors that lack the translational enhancer (Sjöberg and Garoff, 
1996) showed SGs that persist longer in infected cells compared to viruses that contain the 
translational enhancer. It is possible that the translational enhancer, which is a hairpin loop 
(Frolov and Schlesinger, 1994, Sjöberg and Garoff, 1996, Ventoso et al., 2006), allows more 
efficient formation of polysomes and therefore shifts the equilibrium from SGs to polysomes 
(Kedersha and Anderson, 2002) which may contribute to the disassembly of SGs in infected 
cells. This appears to be a passive mechanism to disassemble SGs. On the other hand, the 
FGDF-mediated interaction of nsP3 with G3BP is a targeted, active mechanism. Notably, 
nsP3 contains two FGDF motifs and efficiently binds two molecules of G3BP, whereas 
USP10, which contains one FGDF motif, only binds one G3BP molecule (Paper III Fig. 4). 
The difference in the stoichiometry of the G3BP/USP10 complex compared to the 
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G3BP/nsP3 complex might also explain the rapid disassembly of SGs in alphavirus-infected 
cells. 
The fact that SFV infection leads to disassembly of SG strongly suggests an antiviral role of 
SGs. Interestingly, a direct antiviral role for SGs was shown in VV-infected cells. Cells 
infected with a VV mutant that lacks the PKR antagonist E3L displayed granules which were 
G3BP-, TIA-1- and eIF3-positive, surrounding viral factories and having a direct role in 
restricting viral replication (Simpson-Holley et al., 2011). Our experiments did not show a 
significant difference in the number and appearance of CPVs in cells infected with SFV-wt 
and the mutant viruses SFV-'789 or -F3A, despite the lack of recruitment of G3BP to CPVs 
in cells infected with the mutants. Infection with SFV-'789 led to the formation of SGs at 
similar times post-infection with SFV-wt, which suggests that the kinetics of PKR activation 
and eIF2D phosphorylation are comparable. However it was shown in SINV-infected cells 
that protein production was increased if G3BP expression was knocked down (Cristea et al., 
2010), which suggest an antiviral role for G3BP by limiting gene expression. Other 
possibilities are also likely, for example the restricted production of the 26S sg-RNA, which 
could also lead to a limited gene expression. Furthermore other functions of G3BP could be 
compromised by the knockdown of G3BP, for instance the negative regulation of the DUB 
activity of USP10, which could lead to a stabilization of cellular and viral proteins. 
Interestingly this would suggest that the DUB activity of USP10 may be enhanced in SFV-
wt-infected cells, whereas this activity may be blocked upon infection with the virus mutants 
SFV-'789 and -F3A, where G3BP is not sequestered by nsP3 and therefore free to inhibit 
USP10. Another possible role for G3BP in the replication complex could be related to the 
helicase activity, which resides in G3BP and may dissolve secondary structures in the viral 
RNA. Further experiments are needed to determine if G3BP has a specific role in the 
replication complex of SFV. 
In paper I, we showed that overexpression of nsP3 in the absence of other viral proteins does 
not inhibit the formation of SGs. However overexpression of the polyprotein complex nsP123 
blocked SGs, which suggests that sequestration of G3BP and the formation of replication 
complex-like CPVs is required to block SGs induced by exogenous stress. Experiments with 
overexpressed USP10 revealed similar effects on the formation on SGs. The cells could not 
mount a stress response to exogenous stress, in contrast to cells that expressed the USP10 
mutant F10A, which does not bind G3BP. The HSV-1 ICP8 protein, which we showed to 
bind G3BP as well, is also able to block the formation of SGs. This suggests that proteins 
binding G3BP via an FGDF motif have an inhibitory effect on the SG-nucleating function of 
G3BP. Recent reports indicate that the drug resveratrol is able to inhibit the interaction of 
G3BP with USP10 by interacting with the NTF2-like domain of G3BP, thereby activating the 
DUB activity of USP10 (Oi et al., 2014). Interestingly, resveratrol has two benzene rings that 
sit in similar positions as the phenylalanines of the FGDF motif. It seems that the FGDF-
mediated interaction between G3BP and USP10 is of a mutually inhibitory fashion. USP10 
inhibits the SG-nucleating function of G3BP and G3BP inhibits the DUB activity of USP10. 
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4 FUTURE DIRECTIONS 
So, where can we go from here? In this section, I would like to suggest experiments and 
directions how this work could be expanded.  
In papers I and III, we designed the virus mutants SFV-'789 and SFV-F3A which are unique 
tools to study the stress response in vivo and in vitro, since the two viruses are viable. For 
instance, similar experiments with poliovirus would not be feasible. It was shown that the 
viral protease 3Cpro cleaves G3BP to inhibit the formation of SGs (White et al., 2007). Virus 
mutants with defective 3Cpro are not viable, because 3Cpro is needed for the processing of the 
poliovirus polyprotein. We showed that both SFV-'789 and SFV-F3A are defective in their 
interaction with G3BP, induced more persistent SGs during the course of infection and were 
attenuated for growth in cell culture, by 1.5 and 2 orders of magnitude, respectively; 
compared to SFV-wt. Therefore is to ask would the mutants differ from SFV-wt in their 
capacity to establish viremia in mice? This could be assessed by generating survival curves in 
mice after infection with either SFV-wt or SFV-F3A, possibly accompanied with 
determination of immune parameters. This would provide important information about the 
role of the nsP3-G3BP interaction and the longer persistence of SGs for virus infection in 
vivo. It is possible that the mutant viruses are not causing encephalitis in mice and are not 
lethal. 
Furthermore, it will be interesting to investigate if G3BP has a distinctive role in the viral 
replication complex, to which it is recruited by binding to nsP3. Does the described helicase 
function (Costa et al., 1999) of G3BP have a role in viral RNA synthesis? Infection of cells 
with SFV-wt or SFV-F3A and investigation of the viral RNA synthesis would be appropriate 
experiments to conduct. Furthermore introduction of stem loops, with variable stabilities, in 
the 5´ region of the viral genome or near the subgenomic promoter could give clues if the 
helicase function of G3BP is necessary for efficient replication. Another interesting aspect 
would be to compare the New World and Old World alphaviruses, because New World 
alphaviruses do not sequester G3BP to the replication complexes. Are there any differences 
in the secondary structure of the genomic RNA? 
It has been shown that in uninfected, unstressed cells, G3BP is in complex with the cell 
cycle-associated protein Caprin-1 and the deubiquitination enzyme USP10. In this thesis we 
observed in SFV-wt infected cells that G3BP is recruited to replication complexes, but not 
USP10 or Caprin-1. Continuing this work, it will be interesting to find out what impact this 
exclusion has on the cellular interaction partners USP10 or Caprin-1. It can be hypothesized 
that in the event of G3BP sequestration to viral replication complexes, the interaction partners 
USP10 and Caprin-1 become free to perform reactions. In case of USP10, we could 
investigate whether the ubiquitination levels of its substrates, including the tumour suppressor 
p53, the autophagy modulator Beclin-1 or the NFκB signalling regulator NEMO are changed 
in cells infected with either SFV-wt or SFV-F3A. Analysis on the cell-cycle and migration 
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would be useful to investigate effects on Caprin-1 in infected cells. It is conceivable that the 
sequestration of G3BP enables the activity of USP10 and Caprin-1 to favour viral replication. 
It was shown that Caprin-1 interacts with the NTF2-like domain of G3BP. Interestingly 
Vognsen and colleagues (Vognsen et al., 2013) modelled a conserved peptide of Caprin-1 
into a hydrophobic cleft in G3BP that is situated besides the USP10 and nsP3 binding site. 
G3BP was reported to form dimers but G3BP interacts either with Caprin-1 or with USP10, 
but never both (Nancy Kedersha, Harvard Medical School, personal communication). 
However the G3BP-F33W mutation fails to bind either USP10 or Caprin-1, although the 
suspected Caprin-1 binding cleft was not mutated. This is surprising and raises a number of 
questions. For instance: Why are both interactions disturbed by this mutation? Do both 
Caprin-1 and USP10 bind in the same hydrophobic cleft? Does the F33W mutant affect the 
folding on a larger scale, affecting both binding sites? Tryptophan is a bulkier amino acid 
than phenylalanine, which could mean that the N-terminal DI helix (Fig. 10, Paper III, Fig. 5) 
is pushed aside, making the predicted binding cleft for Caprin-1 smaller and therefore 
preventing the interaction. Creation of further G3BP mutants, which bind either USP10 or 
Caprin-1, would be very helpful to study the two complexes (G3BP/USP10 and 
G3BP/Caprin-1) in terms of their influence on SG formation. 
A regulatory role of these two complexes could be played by the protein OGFOD1, which 
hydroxylates proline residues (Loenarz et al., 2014). OGFOD1 is known to be coprecipitated 
with USP10, Caprin-1 and G3BP (Wehner et al., 2010). Interestingly G3BP contains a 
proline residue at position 8 before the DI helix and at position 27 after the D1 helix. These 
residues could be a target for hydroxylation by OGFOD1, leading for example to 
displacement of the αI helix, which could change the size of the two hydrophobic clefts. 
Therefore the hydroxylation could act as a molecular switch to favour either the 
G3BP/USP10 complex or the G3BP/Caprin-1 complex. This mechanistic switch could 
regulate disassembly (G3BP/USP10) or assembly of SGs (G3BP/Caprin-1). Firstly, 
biochemical studies to determine whether G3BP is hydroxylated by OGFOD should be 
performed as well as interaction studies. Furthermore the G3BP-F33W mutant or other G3BP 
mutants that do not bind USP10 and/or Caprin-1 could be very helpful to study this complex. 
Another newly developed system to study such interactions would be the CRISPR/Cas9 
system which gives the possibility to introduce single point mutations in the genome of cells 
(Jinek et al., 2012, Hsu et al., 2014). With such a tool in hand, the stoichiometry of the 
proteins would be preserved, leading to fewer artefacts than by overexpression or 
knockdown.  
In Paper III we investigated in molecular detail how nsP3 and USP10 bind to G3BP with an 
FGDF motif, where the F3, F6 and the G4 are necessary. Furthermore we discovered that a 
substitution of the residue F33 in G3BP by a tryptophan disrupts the binding to nsP3 and 
USP10. The molecular model that we have presented in this work could lead to the design of 
antiviral drugs that inhibit this interaction. Recently it was shown that the drug resveratrol, an 
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anti-cancer drug, inhibits the interaction between USP10 and G3BP (Oi et al., 2014). Our 
data on the precise molecular nature of the G3BP–FGDF interaction could lead to improved 
derivatives of resveratrol with a stronger binding to G3BP and an improved solubility. 
Furthermore small peptides on the basis of an FGDF motif could be designed to compete for 
G3BP binding and restrict viral replication. 
In summary this work gives valuable information of relevance for a number of human 
diseases, including infection and cancer, both of which involve alterations in stress response 
pathways by providing a detailed molecular mechanism how the SG-nucleating factor G3BP 
is bound by FGDF-containing proteins, such as nsP3, USP10 or HSV ICP8. The mutants that 
have been created during this work are valuable tools to study the G3BP/USP10 and 
G3BP/Caprin-1 complexes. Moreover the virus mutants created in this thesis, where nsP3 
does not sequester G3BP, will also unravel new insights into virus-host-cell interactions and 
the antiviral role of SGs. A lot of work lies ahead of us. 
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